{
  "source_path": "/Users/blank/Documents/Foundation Models Course Projects/Dataset/all_pdfs/አዋጅ-ቁጥር-1354.pdf",
  "source_title": "አዋጅ-ቁጥር-1354",
  "raw_text": " \n nU¶T Uz¤È ±.œ.q.Ü  *¹þ1 \n   Negarit G. P.O.Box 80001 \n ÃNÇ êU\n   Unit Price  \n  \n  \n  \n   \n\u0001\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f\n\u0001\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f\n\u0001\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f\n\u0001\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f \n \n\b\t\n\u0015 \u0016\u0017\u0011\u0003 \u0017\u0018\u0019\n\b\t\n\u0015 \u0016\u0017\u0011\u0003 \u0017\u0018\u0019\n\b\t\n\u0015 \u0016\u0017\u0011\u0003 \u0017\u0018\u0019\n\b\t\n\u0015 \u0016\u0017\u0011\u0003 \u0017\u0018\u0019 \nFEDERAL NEGARIT GAZETTE \nOF THE FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA \n \n \n \n \n \n  \n                        \n                                \u001a\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f \n                                        \u0001\u001b\u001c\u0013 \u001d\u001e\u001f\u0004  !\u000f\" #\u0003 $%&\u0016\u0003 \u0001\u001e\u0019 \n \n \n'()\n'()\n'()\n'() \n*+, -.\" /01234/6078 \n \n\u0001\u0002\u0003\u0004\u0005\u0006 9:;<\u0003 *=\n> *?\u0015@A\u0003 BC  DE:\n'FFG\u0006 *+, ……………………..?J 780K2LK\nContent \nProclamation No.1354/2024 \n \n \nEthiopian  Pharmaceuticals  Supply  Service and  \n Fund  Establishment  Proclamation ...Page 17888 \n  \n*+,\n*+,\n*+,\n*+, -.\"\n-.\"\n-.\"\n-.\" /01234\n/01234\n/01234\n/01234/6078\n6078\n6078\n6078 \n \n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006 9:;<\u0003\n9:;<\u0003\n9:;<\u0003\n9:;<\u0003 *=\n>\n*=\n>\n*=\n>\n*=\n> *?\u0015@A\u0003E BC \n*?\u0015@A\u0003E BC \n*?\u0015@A\u0003E BC \n*?\u0015@A\u0003E BC \n\u00019:;\u0003<\u0003\n\u00019:;\u0003<\u0003\n\u00019:;\u0003<\u0003\n\u00019:;\u0003<\u0003 DE:E\nDE:E\nDE:E\nDE:E M'FF!\nM'FF!\nM'FF!\nM'FF! \u0001\u001e\u0019\n\u0001\u001e\u0019\n\u0001\u001e\u0019\n\u0001\u001e\u0019 *+,\n*+,\n*+,\n*+, \n \n    \n \n \n.\nNO(\n.\nNO(\n.\nNO(\n.\nNO( \u0001\u001dP\u0017?$\n\u0001\u001dP\u0017?$\n\u0001\u001dP\u0017?$\n\u0001\u001dP\u0017?$  9QPN\f\n9QPN\f\n9QPN\f\n9QPN\f 9:;<R E\n9:;<R E\n9:;<R E\n9:;<R E \n\u001a\u001d9\u0019\u0019S \n+\u0017C \nT\u000b&\u0016\u0003 \n%M( \n9\u0015U \nM\u001d$VG( \n\u001b\u0013P\u001dW\u0013 \n'=P\u0013 \n\u0001G\u0006X \u0015 \n\u0001'Y\u001a?\" T9C\f \u00019:;<\u0003 *=\"Z\u0003 QEWM\u0003 \n[\"\\\u0003 9T\"\u0017\u0003 *XD\u000b] \u001a9^_` \n \n\u0001*?\u0015@AaE \n\u0001DE: \n!Eb \n\u001a'Xc\u0003 \n\u001a9E@[\u0003 \n\u0001dC \n\u001dF'\u0003 \n*X\u001d''S \nBC \n\u0001'\u0006F\". \u00019:;<\u0003 *=\"Z\u0003 BE\re\" ':P@C \n\u0001f\u0013P\u001dWgE \nh\u0003i\f \n\u001d$VG\u0016\u0003 \n\u0001G\u0006P\u0017@. \n*W\n\" 9j\u0001X \u001d?> \u001a9^_` \n \n \n\u00019QPN\f 9:;<R  *=\"Z\u0003E \u001a'kk\u0015` \n\u00019:;<\u0003 DE: !EbE l \u00019:;<\u0003 *=\"Z\u0003 \nQEWM\u0003 *9\n\"E l \u00019QPN\f 9:;<R  \n9$%\u001a&\u0006 \u000f! \u0003 *X\u001dm\t\"E BE\rn! \u001d\u0006\u0006o \n*W\np E \nM'$Cq\" \n\u0001G\u0006X \u0015 \n\u001a& \n\u0001\u001b@ \n9QP\u0003 \u001a'XDMr` \n \n \n9:;<\u0003 MdC *?\u0015@A\u0003 \u001esS :\"k \n\u0006M( \u001a9^_ BC MdC( T\"h qG9\t\u001a( \n9+tM \u0016+Y (X. \u00019:;<\u0003 @o qh\u001du(E \n:\"k XMGY\u001c YfE qh\u001du ?ET\u0013 \u001a*@%gC \nMNM9M\u0003 \\\u000b' '+\u0015 \u0001G\u0006X \u0015 (dN' BC \n\u0001v?\" (X. \u00019:v<\u0003 *!\nw E \u0001G\u0006\u001aPNN\n\u00019:;<\u0003 *=\"Z\u0003 [\"\\\u0003 9T\"\u0017\u0003 \u0003UP\u0003 \n\u0014W$( \u0001G?% \u001a9^_` \n \n \n \nPROCLAMATION NO.1354/2024 \n \nETHIOPIAN PHARMACEUTICAL SUPPLY \nSERVICE AND  PHARMACEUTICALFUND \nESTABLISHMENT PROCLAMATION \n \nWHEREAS, it is necessary to build a \nresilient pharmaceutical supply chain system to \navail quality assured essential pharmaceuticals at \naffordable prices and in a sustainable manner to \nthe public; \n \nWHEREAS, it is appropriate to ensure a \nreliable \nand \ncontinuous \nsupply \nof \npharmaceuticals \nin \nthe \ngovernment \nhealth \nfacilities and to devise a mechanism which \nrealizes fair use of the society; by expanding the \nSevice’s source of funds; \n \nWHEREAS, it is appropriate to have \nadequate legal basis; to enhance the source of \npharmaceutical fund, pharmaceutical supply \nchain management, administration of essential \npharmaceuticals \nreserve \nstock \nand \nrelated \nactivities, through improveing access to essential \nmedicines; \n \nWHEREAS, it is considered appropriate to \nestablish an effective Pharmaceutical supply \nsystem which enables the proper use of \nPharmaceutical fund for its intended purpose and \nencouraging  local pharmaceutical manufacturers; \nas the supply of pharmaceuticals has much \nsignificance in health-related services, and the \nshare of Pharmaceutical is relatively very high as \ncompared to health service budget; \n \n31st Year   No.29 \nADDIS ABABA 13th March, 2025 \n   W\u000bs *E\tu \\9\u0003 -.\" xy\n*\rX *\u001a% 9\u0017>\u0003 4 jE 6078 \\.!   \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17889 \n \n\u001a\u0002\u0003\u0004\u0005\u0006 \b\t\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f \n\u001b?-9E@X\u0003 *EjJ 3{(/) 9QP\u0003 \u0001Gq\u001dM( \nN(~\u0015 \n \n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015 *E:\n*E:\n*E:\n*E: \n    \n    \n $=\u000b\u000b\n$=\u000b\u000b\n$=\u000b\u000b\n$=\u000b\u000b \n \n/.  \n  \n  \n  *b\"\n*b\"\n*b\"\n*b\" \"tX\n\"tX\n\"tX\n\"tX \n \n    \nYf \n*+, \n“\u0001\u0002\u0003\u0004\u0005\u0006 \n9:;<\u0003 \n*=\n> \n*?\u0015@A\u0003 BC  DE:  'FFG\u0006 *+, -.\" \n/01234/6078” \u001d\u0013A \u0014$jX Y \u000b\u0015 \n \n6.  \n.  \n.  \n.  \u0003\"\n\u0003\"\n\u0003\"\n\u0003\" \n \n\u0001V *?%\u0013 \u000b \u0003\"r! \u0001G\u0006W$( \u001f\u0015^\u0016 \n\u001aX\u001dj\" \u001af *+, (X.- \n \n// “9:;<\u0003” 'M\u0003 \u0001W(E \u001aNl \u0001\u001d% \n\u001eY! \nd\u0016u \n\u0006\u0015^\u0016 \n*\u001f\u000b\f \n\u001eY! \n*t!p*\f nN \u001eY! \u001d\u0006\u0006o !\u0015\u000fR E \nM99\"9\"l M'q!l M'XN?X \u001eY! \nM9q\u000bq\u0015 \u0001G(\u0015 'Eu(! E.P-\u0016?\" \n\u001eY! \u0001E.P- \u0016?p  (f: ^e %\u0004A\u001f\u0015 \n9:;<\u0003l 'qG\u0006 !@\u0013l \u0001dC \u000feAl \n\u0001dC *?\u0015@A\u0003 M9X$\u0003 \u0001G\u0006XD\u0015@ \n\u000b 'Eu(E! \u0001\u001b\u000f!C 9\u0011\u0006 BC \n\u0001\u001b\u000f!C 9?\u0015?\u0006 \u0006$V\u0015\u000b\u0015` \n \n6/ \n“\u0001\u001b\u000f!C \n9\u0011\u0006” \n'M\u0003 \n\u0001GDM?(E \n\u001d@%\" \nc\"'A\u001f\u0015l \n\u0002G(eA\u001f\u0015 \n\u001eY! NZ\u0014\u000f T \u001a9$j! \u001aj.N \n\u0001G\u0006qC(E 'Eu(E! 9?\u0015?\u0006l =E\u0013P-\n9\u0011\u0006l 9\u001d@\u001a\u0011\u0006l 'El *\u0014\u0006EXl \nW(\u0016\u0003 (X. \u0001Gj9. \u0016?\"l CCE \nqW(\u0016\u0003 (b M99\"9\" \u0001GPm (f: \n\u001eY! \u0001\u0015\u0003 'P\u0017?)l h\u0003\"l tV \n\u001eY! \u000b \u001d9ssY -X ^e \u001a*!\n \n:\",\u0003 M\u0013( \u001eY! \u001a9j\u000bj\u0015 MW( \nf\u000f!C \n.=! \n\u000bY \nBE\r(\u0015 \n\u0001\u001dT\u0017 \n9\u0011\u0006 \u0010^El \u001d\u0006\u0006o \u0001f\u000f!C *?\u0015@A\u0003 \nM9X$\u0003 \n\u001eY! \nB\"@\u001cCE \nM9q\u000bq\u0015 \n\u0001GPm 9\u0011\u0006E \u0006$V\u0015\u000b\u0015` \n \n1/ \n“\u0001\u001b\u000f!C \n9?\u0015?\u0006” \n'M\u0003 \n\u001aNE \nM99\"9\" \u001eY! M'q! \u001a(X. \u001eY! \n\u001a( \u0001W(\u0016\u0003 *\u001f\u0015 .=! \u000bY \u0001G(\u0015 \n'Eu(! 9?\u0015?\u0006 \u0010^El \u0001-X\u0015 9X\u0006 \n\u000fp El \u0010\u0011E El 9\"\b El ckEl \n\u001cE \nl \n..C \n9W\u0015 \n\u001c@,R E \nl \nG\u001fA E BC \u0015\u000e E Y!\n\u0015` \n \n4/ “9QPN\f 9:;<\u0003” 'M\u0003 \u001aG9Mq\u001d( \n*\u001f\u0015 \n\u001aG\u001e\u0019 \n9QPN\f \n\u00019:;<R  \n\u001c\"\u001c\" (X. \u0001\u001d\u001f\u001d\u001d 'Eu(! 9:;<\u0003 \n\u0016(` \nNOW, THEREFORE, in accordance with \nArticle 55 Sub-Articles (1) of the Constitution, it \nis hereby Proclaimed as follows. \n \nPART ONE  \n \nGENERAL \n \n1.   Short Title \n \n \n \n \n \nThis   Proclamation    may  be cited  as   the \" \nEthiopian Pharmaceuticals Supply Service \nand     Fund    Establishment Proclamation \nNo, 1354/2024.\" \n \n \n2.   Definitions \n \nIn this Proclamation, unless the context \notherwise requires: \n \n1/ “Pharmaceuticals” means any substances \nor mixture of substances used in the \ndiagnosis, \ntreatment, \nmitigation \nor \nprevention of human disease, disorder, \nabnormal physical or mental state, or the \nsymptoms thereof; it includes biological \nmedicines, \ntherapeutic \nfood, \nhealth \ntechnology, medical devices, and any \nother medical supplies, which is used as \nan input for providing health services; \n \n2/ “Medical Device” means any instrument, \napparatus, \nimplement, \nmachine, \nappliance, implant, reagent for in vitro \nuse, software, material or other similar \narticles and their accessories which does \nnot achieve its primary intended action \nby pharmacological, immunological or \nmetabolic means, in or on the human \nbody, and intended by the manufacturer \nto be used, alone or in combination, for \nmedical purpose and includes device \nintended for related medical use and \ncontrol of contraception; \n \n \n3/ \"Medical Supplies\" means any article that \nused on the inner or outer part of the \nhuman body for diagnosis or treatment of \ndisease and includes suturing materials, \nsyringes, \nneedles, \nbandages, \ngauze, \ncotton and similar products, chemicals \nand x-ray films; \n \n4/ \"Essential Medicine\" means any medicine \nincluded in the essential medicine list \nissued by the approprate body; \n \n780K2Ly \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17890 \n \n{/ “'qG\u0006 !@\u0013” 'M\u0003 \u0001W(\u0016\u0003 \u001dD.\f \n*W\n\" \u000bY (d\u0003 \u0006\u000bO( \u0001YNGEl \n't:E \u001eY! A  E.P \u0016?p  \u001a\u0016$\u000b \n\u001eY! \u001a\u0019!\n \u0001G?\u001a\u0003C \u001a\u001d\u001eW\u0016 9$E \nBE\r\u001eW: \nNXZ \n\u001a\u001f \u0015l \n\u001aBE\u000f\u0013\u0015l \n\u001a¡¢\u0003l \u001aDsl \u001a$\u0013N \u001eY! \u001a\u000b \n\u001d9ssY nN \u001dT\u0017,R \u0001Gj\"\u0013  !@\u0013 \n\u0016(` \n \n£/ “\u0001dC *?\u0015@A\u0003” 'M\u0003 \u0001\u001aN 9q\u000bq\u0015l \n\u0001'q!l \u0001'??!C 9\u0015 'FF!l \u0001dC \n'\u001a\u0015¤@ BE\rn! \u0001^X¥X BE\u000f\u0013\u001f#E \n\u0006\u001f\u001d\u001d *?\u0015@A\u0003 \u0016(` \n \n8/ “^X¥X” 'M\u0003 \u001a'Y:E \u001aN \u001dYT( \n\u0001fY\u001eNO(E \n9Pk \nMG$%\u001a- \nN'G  \n\u0001\u001b9! \nXVY \nsYW'O( \n*\u001f\u000b\fl X\u0016-\u0015gC\fl '¦\u001a\n\f BC 9EDs\f \nh\u000bNO( \u001d§\u0015R\u000bO( j\u0011 fY\u001eNO(E \nBE\r\u0006s\u0015¨ \nM':P@ \n\u0001GW. \n\u0001dC \n*?\u0015@A\u0003 \u0016(` \n \nK/   “\u0001dC \n\u001dF!” \n'M\u0003 \n\u0001\u001dM\u0006© \n\u0001dC \n*?\u0015@AR E \nM\u001b\u0013P\u001dWg \nM9X$\u0003 \n\u0001\u001dFF9 \n'Eu(! \n\u00019E@[\u0003l \n9E@[N\f \u0006\u0015^\u0016 \u001eY! \u0001@\u0015 \u001dF! \n\u0016(` \n \ny/ \n“BE\t?C \n'ª@\" \n'M\u0003 \n\u00019:;<\u0003 \n*X\u001dkª@E M9\u0017TE 9\t\"\t\u0011\u0006 l M\tE\u001au \n*\u0006\u0006\u001c l M9\u001c BC MX\"b\u0003 !C \n\u001c@¬ \nBE\r^E \n':P@ \n'M\u0003 \n\u0010^El \n\u0001\u000bYu(E \nB@ \n\u001a9hN\u0003 \n9$_E \n\u001a99\" \u001eY! \u001a9j\u0016X 9\u0015 \u0001'ª@ \nBC *(\u0019.R \u0001'ª@ \u001d@%\"E \u0006$V\u0015\u000b\u0015` \n \n \n7/ \n“\u0001'f\u001aPW\u0013 \n9:;<\u0003 \n#\u0003” \n'M\u0003 \nG<X­ %\u001e\u0019( 99\u0011\u0006 \u000bY \u001a\u001dj9® \n99Tu  \n9QP\u0003 \n\u0001GFF! \nBC \n\u0001G\u001dm\t\" 9:;<\u0003 #\u0003 \u0016(` \n \n7// “\u0001*\t\n @o \u001eY! \u0006b ” 'M\u0003 \u001a*\t\n \n\u0001\u001dW$ \u001eY! \u00019\u0019 9:;<\u0003 \u0010^El Mn \n=\u0013\u0013A \nBE\r\u0006?M@\u0015 \n\u001a\u001dT\u0017 \n=J \n9\u001c@Z \u001a'XPq\u0013 \u001eY! \u001a9Pq\u0013 \u001dj%© \n\u001a\u001d\u001eW\u0016 ]\u0018 (X. M\u001dª$( 9:;<\u0003 \u0013 \n\u0001\u001dX'\u001a\u0003E +\u0017 \u0001Gqh\u0015\u001a\u0003l sYª. \n\u0001jP 9:;<\u0003 >e\" @E M*\t\n W( \n\u001d9\u000b \u0001G\u0006\t\"@\u001a\u0003 *W\n\" \u0016(` \n \n \n \n76/ \n“\u0001.!P\u0003 \n@o” \n'M\u0003 \n\u0001\u001dkM \n\u0001+\u0017 \n$jNC \nj\u0019Y\u0016\u0003 \n\u0006M( \n*=\"Z\u0003E \nM'P\u0017?. \u0001\u001dM\u0006© \u001dF'\u0003 \u001eY! v?\n\u0003 \n\u0001@o h\u000bNO(E \u001a*E: \u000bY \u001a'jC\u0003 \n@o \u0001GD¯\u001a\u0003 *W\n\" \u0016(` \n \n5/ “Therapeutic Food” means a concentrated \nsource of vitamin, mineral or other \nsubstance \nwith \nnutritional \nor \nphysiological \neffect, \nalone \nor \nin \ncombination, prepared in a dosage form \nand intended to supplement the regular \ndiet; \n \n \n6/  “Health Service” means a service \nprovided to prevent, diagnose, treat and \ncare a serious health problems and it \nincludes rehabilitation, health system \ndevelopment and hospice services; \n \n \n7/ “Hospice” means a service rendered to \nterminally ill patients in order to reduce \ntheir pain and address their physical, \npsychological, social and spiritual needs; \n \n \n \n8/ “Health Facility” means a public, non \ngovernmental \nor \nprivate \ninstitution \nestablished to render different health \nservicesfor the society; \n \n \n9/ “Repacking” means a process of opening \nthe original package of a pharmaceutical \nproduct and re-packing it in a modified \nquantity to facilitate handling, shelving, \ntransporting, \nand \ndistributing. \nthis \nincludes the kitting process; \n \n10/ \n“Community \nPharmacy” \nmeans \na \npharmacy established and administered \nbased on the criteria stipulated in the \nDirective issued by the Ministry; \n \n11/ \"Consignment Purchase or Sales\" means \na pharmaceutical that has been given or \nreceived based on trust, and by recording \nand handing it over in a form designed to \nbe used for this transfer, the consignee \npays the agreed price only for the \npharmaceutical sold within a certain \nperiod of time; but if there is any \npharmaceutical left unsold, it is returned \nto the consignor; \n \n12/ “Pooled Procurement” means a system in \nwhich different institutions or countries \ncombine their demand or needs to ensure \nbetter value for money and continuous \nsupply by coordinating demand; \n \n780K2° \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17891 \n \n71/ “\u0001*=\"Z\u0003 [\"\\\u0003” 'M\u0003 qh\u000b\u0003 \u0003E\u001dC \n!p \n9:;<\u0003E \ndC \n\u001dF! \n:PX \nBXq'=P\u0013 \n\u0006 \n\u001d@%\n\u0003E \n\u001a \n\u0006$V\u0015\u000b\u0015` \n \n74/ \n“\u0001=:G\u0006 \n(\u0015 \n\u0001G?%\u001a\u0003 \n\u0001*=\"Z\u0003 \n[\"\\\u0003” 'M\u0003 \u001a\u001a\u0003 \u0001\u001d\t?D \u00019:i<\u0003 \nh\u000b\u0003 \n\u000bY \n\u001a\u001d9QP\u001d \n9E?: \ndC \n\u001dF'\u0003 \n\u001a=:G\u0006 \nq*?\u0015@Aa \n\u0017\" \n\u001aGD¯\u0003 (\u0015 9QP\u0003 \u0001GX\u001dC?¡\u001a\u0003 \n[\"\\\u0003 \u0016(` \n \n7{/ “X\u0003\n±\f \u00019$%\u001a&\u0006 \u000f! \u0003” 'M\u0003 \n\u001a\u001dD.p l W( W\n *\t\u0017  BC\n\u001a\u001eP\"S \n\tP± \nMGqWa \n\u001aN  \n9q\u000bq\u0015C \n'q! \n\\\u000b' \n\u0001GT\u0017, \nBC \n\u001e=N\f 'kk\u0006 \u0001G\tP@\u001a\u0003 \u00019QPN\f \n9:;<\u0003 \n\u001c\"\u001c\"E \n9QP\u0003 \n\u001a':P@ \n\u0001G\u0006\u001c  \u000f! \u0003 \u0016(` \n \n7£/ “*=\n>” 'M\u0003 \u001av?\" (X. \u001eY! \u001a( \nv?\" \n\u001a'!P\u0003 \n\u001eY! \nq(b \nv?\" \n\u001a'X9\u0019\u0003 \nM*?\u0015@Aa \n9:;<\u0003 \nM'=P\u0013 (\u0015 \u0001?% 'Eu(! W( \u0016(` \n \n78/ “\u0001*?\u0015@A\u0003 \u000fh\u0006 !\u0019“ *?\u0015@Aa \nq\u001d?\u000b%b DE: !Eb ( q@o l \nq\u000f! \u0003 BC qX\"b\u0003 *?\u0015@A\u0003 \u0017\" \n\u001a\u001d\u0006\u0006T \nMA  \n*\u001f\u000b\u0003 \nMGW$( \n*?\u0015@A\u0003 \u0001G\u0006XqhM( \u0001*?\u0015@A\u0003 \u000fh\u0006 \n!\u0019 \u0016(` \n \n7K/“\u0001\u0006b fm@“ 'M\u0003 \u001a*?\u0015@Aa \u001d?\u001c\u001d( \nMdC \n\u001dF§\u0003 \nMGj\"g \n9QPN\f \n9:²<R C \u0001f\u000f!C 9?\u0015?\u0006  \u000bY \n\u0001G\u0019\u0015 fm@ \u0010^E \u001a9[\u0011\u0006 #a \u0001\u001e® \n*$V\u000bY \u0001@o \u001e  \u000bY \u001d9[\"R \n\u0001G\u0019\u0015 fm@ \u0016(` \n \n7y/    “DE:” \n'M\u0003 \n*?\u0015@Aa \nM9:i<\u0003 \n9@³C \u001d\u0006\u0006o *?\u0015@AR E M9X$\u0003 \nBE\rn! M\t9\u001e\u001c BC MX\n 'X± \n\u0001G$j!\u001a\u0003 \n?ET\u0013 \n\u0010^E \nq9:i<\u0003 \n\u0006b BC qA  \u001a*+¬ \u0001\u001dDj¡ \u0001?> \n!E´  \u0001G?S ?>E Y!\n\u0015` \n \n \nx “\u001d?\u000b%b DE:” 'M\u0003 *?\u0015@Aa \u001af \n*+, q\u001d?Mµ \u0001DE: !E´  \u0001G\u0006?¶(E \n?> \n\u001a9$j! \n9:i<\u0003 \nq? \n\u001a·\u000b \n9:i<aE \nMdC \n\u001dF'\u0003 \n\u001a\u0006b \n\u001a'W\n\u0003 q\u0006b \u0006?¶(E ?> 9\u0015 \nM9:i<\u0003 9@³ \u0001G$j!\u001a\u0003 9^_E \n\u0001G\u00069M\u000f\u0003 \u0016(` \n \n \n \n \n13/ “Supply System” means all activities \nfrom demand analysis upto delivery of \nmedicines to the health facility; \n \n \n14/ \"Committed Demand System\" means a \nbudget-supported quantification system \nin \nwhich \npharmaceuticals \nwill \nbe \nsupplied to health facilities based on the \ncontract they entered with the Service in \nadvance; \n \n15/ “Strategic Reserve Stock” means stock \nlevel reserved for natural, man made \ndisasters and possible emergency based \non a list of pharmaceuticals prepared and \nperiodically updated for the purpose of \nprevention and treatment of epidemic or \npandemic diseases; \n \n16/ “Supplier” means a natural or juridical \nperson under contract with a public body \nto supply medicine for the service by \nproducing or  importing  in the  Country \nor abroad; \n \n17/ \" Service Charge \" is the service fee rate \nto be determined by the Service for the \nprocurement, storage and distribution \nservices it provided for any third party, \nwho require such services; \n \n \n18/ \"Sales Margin\" ”:- is a percentage added \non \nthe \nselling \nprice \nof \nthe \nPharmaceuticals for the purpose of \ncompensating the cost incurred by the \nService to purchase, store and distribute \nthe pharmaceuticals purchased from \nrevolving drug fund source; \n \n19/ \"Fund\" means the money used by the \nService \nfor \nthe \npurchase \nof \npharmaceuticals and related services, as \nwell as for salaries and operations, and \nincludes income from the selling of \npharmaceuticals and from such other \nsources of income permitted by the \nProclamation; \n20/ \"Revolving Drug Fund\" means a fund \nobtained from the sources specified in \nthis Proclamation and to be used for the \npurchasing of pharmaceuticals, which \nwill be replenished later after the \ndistribution of the same to the health \nfacilities through sales and the proceed \nfrom sales will be used again for the \npurchase of pharmaceuticals in revolving \nmanner; \n780K2°/ \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17892 \n \nx// “\u0001@!± #\u0003 W\u0016:” 'M\u0003 \u00019E@X\u0003 \n\u0001\u001a\u0003 r:M\u0003E M9ªDE \\\u000b' \u0001G(\u0015 \n?ET\u0013E \nM'W%W\u0013 \n\u001a\u0013¸\n\f \n%E\u000f \n*'\u001fS\u0016\u0003 M?\u001a\u0006 \u0001Gj\"\u0013 \u0001\u0013\" W\u0016: \u0016(` \n \nx6/ \n“\u0001\u001f¥N\u0015 \n\u001e” \n'M\u0003 \n*?\u0015@Aa \nqGW$( *?\u0015@A\u0003 \u0017\" \u001aj.N @E\u0016\u0003 \n\u0006\u000bO(E \nBE\t9\u0017TE \n@E%N \nl \n\u0001\u0002E¹\"E \u000feA 9QP\u001d \u0015'\u0003 \n\u001c\"\u0017N l \u0001\u001dªq\"\u001f\u0011  @o l \u001e.T.\u001d …. \n\u0001G\u0006\u001f\u0003\u0003 \u001e \u0016(` \n \nK1/ \n“\u000f\u0015\u0015” \n'M\u0003 \n\u001a\u0002\u0003\u0004\u0005\u0006 \n\b\t\n\u000b\f \n\r\u000e\u000f\n\u0010\u0006\f \u0011\u0012\u0013\u0014\u000f \u001b?-9E@X\u0003 *Ej¯ \nº8 9QP\u0003 \u0001\u001dFF9 \u000f\u0015\u0015 \u0010^E \u0001*\rX \n*\u001a% BC \u0001:»m+ q\u001d' *X\u001dm\tp E \nY!\n\u0015` \n \n \nx4/ \n“G<X\"” \n\u001eY! \n“G<X\u0003\"” \n'M\u0003 \nBE\t=\t! \u001dq\u001d \u0001dC G<X\" \u001eY! \nG<X\u0003\" \u0016(` \n \n \nx{/ “\u0001G9Mq\u001d( *\u001f\u0015” 'M\u0003 \u001af *+, \n\u000bY \u0001\u001d$j  \u001d@%\n\u0003 \u001aGqC\u001e_\u001a\u0003 ]\u0018 \n:\"k \u0006M(C \u001a\u001b@ X\u0015\u0019E \u0001\u001dW$( *\u001f\u0015 \n\u0016(` \n \nx£/ “W(” 'M\u0003 \u0001\u001dD.p W( \u001eY! \u001a\u001b@ \n\u0001W(\u0016\u0003 9\u0013\u0003 \u0001\u001dW$( *\u001f\u0015 \u0016(` \n \nx8/ 'Eu(! \u001a\u001eE: ¼N \u0001\u001d?M¤ *?\u000bMJ \n½\u0003E! Y!\n\u0015 \n \n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015 nM\u0003\nnM\u0003\nnM\u0003\nnM\u0003 \n   \n\u00019:;<\u0003\n\u00019:;<\u0003\n\u00019:;<\u0003\n\u00019:;<\u0003 DE:\nDE:\nDE:\nDE: \n \n1.  \n.  \n.  \n.  9FF!\n9FF!\n9FF!\n9FF! \n \n\u00019:;<\u0003 DE: (qf \u001a·\u000b “DE:” B\u0001\u001d%M \n\u0001G$\n) \u001af *+, \u001dF-§\u0015 \n \n4.  \n.  \n.  \n.  XMDE¡\nXMDE¡\nXMDE¡\nXMDE¡ \u0001?>\n\u0001?>\n\u0001?>\n\u0001?> !E´ \n!E´ \n!E´ \n!E´  \n \nDE¡ \u0001Gq\u001d\u0003 \u0001?> !E´  Ye­N\u0015- \n \n//  q9:;<\u0003 \u0006b` \n \n6/ q9:;<\u0003 @o l \u000f! \u0003 l [\"b\u0003 BC \n\u001d\u0006\u0006o *?\u0015@AR  qG?S ?>` \n \n \n1/ q9E@X\u0003 \u001a\\Y\u0016\u0003 \u001eY! \u001a?ET\u0013 qGW. \n:\u0017h` \n \n \n \n21/ \"Treasury Bill\" means a Bond offered to \nthe market by a National Bank of \nEthiopia to raise money aiming to cover \nthe government's budget deficit; \n \n22/   \"Capital \nExpenditure\" \nmeans \nthe \nexpenditure directly related to the service \nprovided by the service, such as \nconstruction of warehouse, development \nof information technology infrastructure, \npurchase of vehicles, etc; \n \n \n23/ “Region” means member states of the \nFederal Democratic Republic of Ethiopia \nlisted \nunder \nArticle \n47 \nof \nthe \nConstitution of the Federal Democratic \nRepublic of Ethiopia and includes the \nAddis Ababa and Dire Dawa City \nAdministrations; \n \n24/ “Minister or Ministry”means the Minister \nor the Ministry of Health respectively; \n \n25/ “Appropriate body” means the body that \nhas a stake and is authorized by law \nwhen the activities mentioned in this \nProclamation are carried out; \n \n26/ “Person” means a natural or juridical \nperson; \n \n27/ Any expressions in the masculine gender \nincludes the feminine. \n \nPART TWO \n \nPHARMACEUTICAL FUND \n \n \n3.   Establishment \n \nPharmaceutical Fund (here in after referred to \nas “The Fund”) is here by established. \n \n4.   Sources of the Fund \n \nThe Fund shall have the following sources: \n \n1/ Revenue generated from pharmaceuticals \nsells; \n \n \n2/ Revenue generated from procurement, \nstorage, distribution and other related \nservices;  \n \n \n \n3/ Resources allocated by the government in \nkind or in cash; \n \n \n \n780K2°6 \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17893 \n \n4/ qM\u0017 *\u001f\u000b\u0003 \u001a\\Y\u0016\u0003 \u001eY! \u001a?ET\u0013 \nqGW. t\"mN` \n \n{/ \u00019$jG\u0006  ]\u0018\u0006O(  \u0006MD  BC  q*?\u0015@A\u0003\n ( \u0001^_  9:;<R E  \u001a'X\u001e?:  qG?S \n?>` BC \n \n£/ \u001af *+, 9QP\u0003 q\u001dDj¡ A  \u0001?> \n!E´   \n \n{.  \n.  \n.  \n.  \u0001DE¡\n\u0001DE¡\n\u0001DE¡\n\u0001DE¡ \\\u000b' \n\\\u000b' \n\\\u000b' \n\\\u000b'  \n \n\u0001DE¡ \\\u000b'  \u0001Gq\u001d\u0003 CO(- \n \n \n// qh\u001du ?ET\u0013 \u0001G$Yj(E \u00019:;<\u0003 \n@ol \u000f! \u0003  BC  X\"b\u0003  \u001eE *?\u0015@Aa \n\u001aG\u0006X\u001dm:P( \u001d?\u000b%b DE: BE\rªDE \n':P@` \n \n6/ \n\u0001*=\"Z\u0003 \nWEWM\u0003E \n9QP\u001d \n\u0015'\u0003E \n\u001a'\u0015\u001a\u0003 ` \u001a'Xcc\u0003 BC \u001a'T9E \n\u00019:i<\u0003 *=\"Z\u0003 T\u000b&\u0016\u0003E 'P\u0017?.` BC \n \n \n1/  \u00019E@[\u0003 \u001a\u0003 \u0001\u001e )CE 9j\u0016X  \n \n£.  \n.  \n.  \n.  \u0001DE¡\n\u0001DE¡\n\u0001DE¡\n\u0001DE¡ *$Vj!C\n*$Vj!C\n*$Vj!C\n*$Vj!C *X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\" \n \n// DE¡ \u001a*?\u0015@Aa X! \u001a\u001dqD\u001d \u0001%E\u000f \n¾\u0013 \u001dj'b Y^C\u0015 \n \n \n6/ DE¡ \u001a+\u0016u\u0016\u0003 M9:;<\u0003 @o BC \nM9:;<\u0003 *=\"Z\u0003 *?\u0015@A\u0003 'Xc\u0006C \n'$Cq\u0011\u0006 \n\u0001G(\u0015 \n\u0010^El \nBE\rn! \n\u0001*?\u0015@AaE \\\u000b' M'XD¤! MG\u0006XD\u0015r \n\u001e  Y(\u000b\u0015 \n \n1/ \u0001DE¡ ?ET\u0013 \u0001\u001f¥N\u0015 \u001e E M9ªDE \n\u0001G(M( Z\"¡ \u001af *+, *EjJ 71 \nE¿X *EjJ (1) 9WP\u0003 \u0010\u001eXE Y^C\u0015 \n \n4/ \u0001DE¡ \n*X\u001dm\t\" \n\u00019E@X\u0003 \ncYCEX \n*X\u001dm\t\" [\"\\\u0003E \u001dq\u0003A YD¤'\u0015 \n  \n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015 ÀX\u0003\nÀX\u0003\nÀX\u0003\nÀX\u0003 \n  \n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006 9:;<\u0003\n9:;<\u0003\n9:;<\u0003\n9:;<\u0003 *=\n>\n*=\n>\n*=\n>\n*=\n> *?\u0015@A\u0003\n*?\u0015@A\u0003\n*?\u0015@A\u0003\n*?\u0015@A\u0003 \n \n8.  \n.  \n.  \n.  9FF!\n9FF!\n9FF!\n9FF! \n \n// \u0001\u0002\u0003\u0004\u0005\u0006 \u00019:;<\u0003 *=\n> *?\u0015@A\u0003 \n(qf \u001a·\u000b “*?\u0015@A\u0003” B\u0001\u001d%M \u0001G$\n) \n\u0001\u001b@ W(\u0016\u0003 \u0006M( \n E \u0001M \u0001\b\t\n\u0015 \n9E@X\u0003 9X\u0011\u0006 #\u0003 ^e \u001af *+, \n\u001dF-§\u0015 \n4/  Grants obtained from donor, partners in \nkind or in cash; \n \n5/ Revenue generated from disposal of \nexpired and out-of-service medicines; and \n \n6/ From other sources of income permitted in \nthis Proclamation. \n \n5.   Objectives of the Fund \n \nThe following are objectives of the Fund: \n \n \n1/ For \ncovering \nthe \nhigh \ncost \nof \npharmaceutical procurement, storage and \ndistribution by using the revolving drug \nfund to be adminstered by the Service; \n \n2/ Ensuring sustainability of pharmaceutical \nsupply by developing, expanding and \nmodernizing \nthe \nsupply \nchain \ninfrastructure; and  \n \n \n3/ To reduce the expenditure burden on the \ngovernment budget. \n \n6.   Utilization and Administration of the Fund \n \n1/ The Fund shall be deposited in a bank \naccount opened in the name of the \nService. \n \n2/ The Fund shall mainly be used for the \nprocurement of pharmaceuticals and for \nexpanding \nand \nstrengthening \npharmaceutical services; it shall also be \nused to cover other costs associated with \nimplementing the Service’s mission. \n \n3/ The Fund shall be used for capital \nexpenditure, when the board decides \nbased on Article 13 Sub-Article (3) of \nthis Proclamation. \n \n4/ The management of the Fund shall be \ncarried out based on the government \nfinancial management system. \n \nPART THREE \n \n \nETHIOPIAN PHARMACEUTICAL SUPPLY \nSERVICE \n \n7.   Establishment \n \n1/ The Ethiopian Pharmaceutical Supply \nService (hereinafter referred to as \"the \nService\") is hereby established as an \nautonomous federal public body having \nits legal personality. \n780K2°1\n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17894 \n \n6/ *?\u0015@Aa \u001d$\u0011\u0016a MG<X­ Y^C\u0015 \n \nK.  \n.  \n.  \n.  +C\n+C\n+C\n+C 9[\u0011\u0006\n9[\u0011\u0006\n9[\u0011\u0006\n9[\u0011\u0006 #\u0003\n#\u0003\n#\u0003\n#\u0003 \n \n\u0001*?\u0015@Aa +C 9X\u0011\u0006 #\u0003 \u001a*\rX *\u001a% q\u001d' \n^e` BE\t *XD\u000b]\u0016a \u001a'Eu(! [h\n \n=\"E)¹  \u0014e­\u0003 Y \u000b\u0015 \n \ny.  \n.  \n.  \n.  \u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa \\\u000b' \n\\\u000b' \n\\\u000b' \n\\\u000b'  \n \n\u0001*?\u0015@Aa \\\u000b'  \u0001Gq\u001d\u0003 CO(- \n \n// M9E@[\u0003 dC \u001dF'\u0003 BC M9E@[\u0003 \n'f\u001aPW\u0013 \n9:;<\u0003 \n#R  \n.\nNO(l \n\tfE\u0016NO( BC D+\u0016NO( \u0001\u001dP\u0017?$ \n9QPN\f 9:;<R E \u001a\u001d9\u0019\u0019S +\u0017l \nj\u0019Y\u0016\u0003 %M( BC \u001e=aE \u001a$\u001aj 9\u0015U \n'=P\u0013`BC \n \n6/   \u001av?\u0011a     \u0001dC     Á\u0014\u0010     \u000bY     \u0001\u001d9QP\u001d\n\u00019:;<\u0003 \n*=\"Z\u0003E \n\u001a'$Cq\"C \nTM¢N\f\u0016aE \n\u001a'P\u0017?. \nh\u0003i\f \n\u0001dC \n*?\u0015@A\u0003E \nM'Xc\u0003C \nM'$Cq\" \n\u001aG\tP?( \u0001\u0015'\u0003 BE=XV½ *X\u001d+¯Â \n':P@ \n \n7. \n. . \n. \u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa [\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC \u001d@%\"\n\u001d@%\"\n\u001d@%\"\n\u001d@%\" \n \n*?\u0015@Aa \n\u0001Gq\u001d\u0003 \n[\u0015\u0019EC \n\u001d@%\n\u0003 \nYe­N\u0015- \n \n// \n9QPN\f \n9:;<R E \n\u001a\u001a& \n9$El \n\u001a\u001d9\u0019\u0019S +\u0017C j\u0019Y\u0016\u0003 %M( 9\u0015U \nM9E@[N\f \nBE\rn! \nBE\t*XD\u000b]\u0016a \n9E@[N\f \u000b\u0015^_ \u001eY! M@\u0015 \u0001dC \n\u001dF'\u0003 '=P\u0013` \n \n \n \n6/ \u001af *Ej¯ E¿X *Ej¯ (/) \u0001\u001d\t\u0016??( \n>e\"!l \u0001GW$( *?\u0015@A\u0003 \u001e Ã\u0019>l \nq*= \u0017\" \u0001\u001d?CT\u001a l j\u0015\u0019c BC \n(dN' BE\r^E M':P@ *?\u0015@Aa \n\u0001\n E \u00019:;<\u0003 @o \u001c\"\u001c\" \u0014\u0006T\u0017, \nY \u000b\u0015` \n \n1/ M9:;<\u0003 *=\"Z\u0003 (dN'\u0016\u0003 *\u0017o \n\u0001^\u0016 \nT9C\f \n\u0001@ol \n\u0001\u000f! \u0003 \nBC \n\u0001[\"b\u0003 [\"\\\u0003E \u0006Xcc\u0015l\u0006$C\u000f\n\u0015l \nY\u001d?\u0013\n\u0015l YqN\u001d\u000b\u0015` \n \n4/ \n\u0001v?\u0011aE \n\u0001dC \nÁ\u0014\u0010l X\u0003\n \nBC \n=:G\u0006 \n\u0001GW\u0019O( \n\u0001dC \n @p E \n9QP\u0003 \n\u001a':P@ \nMdC \n*?\u0015@Aa \n\u0001G\u0006XD\u0015r 9:;<R E \u0006j\"%\u0015` \n \n \n2/ The Service shall be accountable to the \nMinistry. \n \n8.   Head Office \n \nThe Head Office of the Service shall be in \nAddis Ababa and may have branch offices \nelsewhere as necessary. \n \n9.   Objectives of the Service \n \nThe objectives of the Service are: \n \n1/  To ensure the provision of quality, safety \nand \nefficacy \nassured \nessential \nphamaceuticals at affordable prices in a \nsustainable manner to public health \nfacilities and government community \npharmacies; and \n \n2/    Contribute to the development endeavor \nof expanding and strengthening equitable \nhealth services based on the country’s \nhealth policy and through enhancing and \nensuring availability of pharmaceuticals. \n  \n \n \n10.   Powers and Duties of the Service \n \nThe Service shall have the following powers \nand duties: \n \n1/  To provide pharmaceuticals included in \nthe essential drug list in sufficient \nquantities, at affordable prices in a \ncontinuous manner to public health \nfacilities \nand \nwhen \nit \nis \ndeemed \nnecessary \nto \nnon-governmental \nand \nprivate health institutions as well; \n \n2/ Notwithstanding the provision of Sub-\nArticle (1) of this Article, the Service \nmay prepare its own pharmaceutical \nprocurement list commensurate with its \ncapacity in order to make its service \nmore efficient and effective; \n \n3/ Expand, strengthen, implement, and \nmonitor a modern procurement, storage, \nand distribution system which leverages \nefficient and effective pharmceutical \nsupply; \n \n4/ Based on the country's health policy, \nstrategy \nand \npriority, \nit \nprovides \npharmaceuticals and medical supplies \nneeded for the health service; \n \n \n780K2°4 \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17895 \n \n{/ T9C\f \u00019:;<\u0003 'q'l \u0001BE\t?C \n'ª]\u0006 \nBC \n\u0001[\"b\u0003 \n*(Np E \nYTP\u0017\u0015l \u0006$C\u000f\n\u0015` \n \n£/ \nq*?\u0015@Aa \n\u0001[\"b\u0003 \n*W\n\" \n\u0017\" \n\u0001G\u0019\u0019! \nT9C\f \n\u0001A,XÄ\u000fX \n9P± \n\u0015((. [\"\\\u0003E Y?\u0016%\u0015` \n \n8/ 9:;<R E \u001aj.N M^X¥NA  BC dC \n\u0019>\u0006  M':PX \u0001G\u0006X \u0015 j\u0015\u0019cC \n(dN' \n*W\n\" \nYjYs\u0015` \nYTP\u0017\u0015` \nY\u001d?\u0013\n\u0015` YqN\u001d\u000b\u0015` \n \nK/ @\u0015¯\u0016\u0003 BC \u001d$\u0006&\u0016\u0003 \u0001WD\u0016\u001a\u0003 \u0001*W\n\" \nX\u0015\u0003 \n\u001a9j\u0001X \n9:;<R E \nq\u0013\u000f\u0016\u0003 \n\u0001Gq\u000bq\u0015 \u0001*=\"Z\u0003 [\"\\\u0003E YTP\u0017\u0015` \nY\u001d?\u0013\n\u0015` \n \ny/ *XD\u000b] ^e \u0010?S \u001a9:;<\u0003 h\u000b\u0003 BC \n*=\"Z\u0003 \n9\u001fq\u0015 \n\u0001GD$\" \n\u000fh\u001d\u0003E \nq9\u000b\u0003 \u001eY! ?\u001a\u0006E q'P\u0017\u0017\u0003 *EÅ\" \n\u0001\u001d9P® 9QPN\f 9:;<R E M@\u0015 \ndC \u001dF'\u0003 \u001a'=P\u0013 9:;<R \u001a\u001a& \n9$E \nBC \n\u001a\u001d9\u0019\u0019S \n+\u0017 \nMdC \n*?\u0015@A\u0003 D\u000b](  \u001b\u0013P\u001dW\u0013 \u0001G\t\" \u001a\u0003E \nnN \u00069\u0015` \n \n7/ M9:i<\u0003 'q' \\\u000b' \u0006X?\u0016%O(EC \n\u001e\t\u0003 \u0001G\u0006X?\u0016%O(E  9\u0017Te  BE\rn! \nA  \n\u00019QP\u001d \n\u0015'\u0003 \n*(Np E \n\u001a'Y$j!\u001a\u0003 \n]\u0018 \nBE\t*XD\u000b]\u0016a \nM\u001dM\u0006© *?\u0015@A\u0003 D\u000b]  \u001a'q\n\u0001\u0003 \n?>(E \nM9:i<\u0003 \nDE: \n'$Cq\u0011\u0006 \n\u0006(\u000b\u0015` \n \n \n7// \n9P±E \n9QP\u0003 \n\u0006\tP? \n\u00019:;<\u0003 \n*=\"Z\u0003 BE\re\" \u0001G\u0006X \u0015C M\\\u000b'( \n9s\u001f\u0003 \u0001GPm \u00019P± 'tq\u0015 \u0006\tP±\u0015` \n \n76/ \u001d\u0015t(E M's\u001f\u0003 \\\u000b' \u00019:;<\u0003 \n*=\"Z\u0003 WEWM\u0003 \u000bY \u0006\u001dP X\u0015$CC \n.C\u0003 \u0006\u001f¾m\u0015  \u001d\u0006\u0006o  \u0001!\u000f\"  *?\u0015@A\u0003! \nYW\u0019\u0015` \n \n71/ q9:;<\u0003 *=\"Z\u0003 \u0017\" \u001a\u001d\u0006\u0006T f\u001c\u0013 \nBC %M:\"k *\u001f\u000b\u0003 \u0014\u0006(FO( \u0001G?g \n9P± E \nYc \nBC \n\u001aj\u000b \n\u001d\t\n \nM':P@ \n\u0001G\u0006X \u0015 \nT9C\f \n\u00019P± \n\u0015((. [\"\\\u0003 YTP\u0017\u0015` \n \n74/ \u0001.!P\u0003 @o` \u0001*\t\n @oC \u0006b \nBE\rn! \n\u0001B, \n\u001aB,C \n\u0001¡# \n\u0006b \n\u0006qC(C\u0015` \n \n \n \n5/ Establish, expands and strengthens modern \npharmaceutical \nstorage, \nre-packaging \nand distribution networks; \n \n6/ Establish a modern logistic information \nexchange system aligned with the current \nhealth supply chain system of the \nService; \n \n7/ Design, develop and implement an \nefficient \nand \neffective \ndistribution \nsystem; which enables direct delivery of \npharmaceuticals to health facilities; \n \n8/ Develop and implement a transparent, \naccountable, cost-effective and efficient \noperational strategy of pharmaceutical \nsupply system to prevent pharmaceutical \nwastage; \n \n9/ When appropriate, it supplies selected \nessential medicines to private health \nfacility in efficient quantity and with \naffordable price to fill the gap between \ndemand \nand \nsupply \nof \nthe \npharmaceuticals or to stabilize the \nmarket; \n \n \n10/ When appropriate, the Service may rent \nout the warehouses it has built, may \nbuild in the future and its other \ninfrastructure \nfacilities \nto \nanybody \nseeking such service and use the \nproceeds \nfor \nenhancing \nthe \npharmaceutical fund; \n \n11/ Organizes a data center, which enables \ninformation-based \ndelivery \nof \npharmaceuticals and enables the Service \nto achieve its objectives; \n \n12/ Conduct supply chain training and studies \nincluding rendering related consultancy \nservice for the purpose of achieveing its \nobjectives; \n \n13/ Through modernizing the information \nexchange system, it enables the general \npublic and stakeholders to easily access \nthe information they suppose to know, in \nrelation to the supply of pharmaceuticals; \n \n14/  It carries out; pooled procurement, \nbuying and selling based on consignment \nand transacts on cash and credit basis; \n \n \n780K2°{ \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17896 \n \n7{/   M9:;<R  \n*=\"Z\u0003 \n*?\u0015@A\u0003 \n\u0001G\u0006XqhM(E \u0001\u000fh\u0006 9\u0019  BC \u0001\u0006b \nfm@ \u001aZ\": \u0006X\u001eXC\u0015` \n \n \n \n \n7£/ qGW$( \u00019:;<\u0003 @o` \u000f! \u0003C \n[\"b\u0003 \n*?\u0015@A\u0003 \n\u0017\" \n\u001a\u001d\u0006\u0006T \n\u000fh\u0006 E YW\u001aX%\u0015` \n \n78/ \\M!*jh :\",R E !p qA  \n*\u001f\u000b\u0003 \nMG<X­ \n\u001at\"mN \n\u0001GW® \n9:;<R E \nG<X­ \n\u0001G\u0006\u001e\u0019(E \n99\u0011\u0006 9QP\u0003 \u001a':P@ \u0006X\u001dm:\n\u0015` \n \n7K/ qG\u0006qC(CO( \u001d@%\n\u0003 (X. \u001a@\u0015 \n:\",R  >qC\u001e_ \u0001\u001dkM =\u0015.hC BC \n\u0002eG\u0006\f $jN \u0001G\u0006X?\u0003E \u001a.C\u0003 \n\u001a9M\u0001\u0003 qX\u001du \u001e?E \u0017\" \u001aGD¤! \nX!!\u0016\u0003 \u0001GW­\u001a\u0003E nN \u00069\u0015` \n \n7y/ \u00019E@X\u0003 BC \u0001@\u0015 *\u0017\"\u0016\u0003 \u0001G9\n\u001a\u0003E \n*$V\u000bY \u001b@C 99\u0011\u0006 9QP\u0003 \u001a':P@ \nqv?\" (X. \u0001\u001b\u000f!C @\u0013\\\u0003 *!\nw  \nBC \nA  \n\u001aT\"¨ \nq\u001dW'­ \n\u0001@\u0015 \n\u001dF'\u0003\u0017\" \n\u001aX\u0003\n\u001f\f \n*\u0017\"\u0016\u0003 \n\u000bY \n\u001a\u001d9QP\u001d 9E?: \u001a\u0003\u0013\u0013\" YW\n\u0015`  \n \nx/ q\u001dFF9\u001a\u0003 \\\u000b' \u0017\" \u001a\u001d?C¶ :\u0017h \nqG\u0006\t\"r \\M! *jc\fl *fr\n\fC v?\" \n\u001aj\u0015 :\",R  BC %M:\"k *\u001f\u000b\u0003 \u0017\" \n\u001a\u0003\u0013\u0013\" YW\n\u0015` \n \n \nx// *X\u001d''S \u00019:;<\u0003 *=\"Z\u0003 BE\re\" \nq':P@ *EÅ\" qG9MqNO( *\u001f\u000b\u0003 \u0017\" \n\u001a\u0017\n YW\n\u0015` \n \n \nx6/  q.!P\u0003  @o \u0014?S  \u0001G M(E \u0002eG\u0006\f \n$jN Ns> \u001a':P@ \u001av?\n\u0003 9\u001fq\u0015 \n\u001aG\tP@ \nX!!\u0016\u0003 \n\u001a\u0017\n \n\u0001G?Æ \n9:;<R E \nM9qcD\u0015 \n\\\u000b' \n\u001eY! \n\u0001f\u000f!C *W\u0019.E !C (dN' BE\r^E \nM'X\u0015 \n9:;<R E \nBE\t?C \n\u001a'ª@ \n\u001av?\" (X. \u0006W\n)\u0015` BE\t *XD\u000b]\u0016a! \n\u001e\tG9MqNO( v?\n\u0003 Y\u0015\u001f\u0015` \n \n \nx1/ *?\u0015@Aa qG\u0006qC(\u0016( \u0001@ol \u0001\u000f! \u0003 \nBC \u0001[\"b\u0003 X\n \u0017\" \u001a\u001d\u0006\u0006T \u0006\u001e\u0019(E \n\u001e q*?\u0015@A\u0003 $\u0006& \u0001G\u0006X\u001d\u001f\u001a\u0003E \n\u0001\u000fh\u0006 9\u0019 BC \u0001*qcD\u0015  99\u0011\u0006 \n\u001aZ\": \u001a'X\u001eWE \u001d@%\n\f \u0006\t\"\u0017\u0015` \n \nx4/   \u001a9:;<\u0003 \n*=\"Z\u0003 \nWEWM\u0003 \nBC \nAXÄ\u000fX Æ\u0011\u0006 G<X\u0003­E \u0006'\u000f\n\u0015` \n \n \n15/ It proposes, the service fee and sales \nmargin for rendering the supply of \npharmaceuticals, to be decided by the \nBoard; \n \n16/ Collect receivables associated with \nprocurement, storage and distribution \nservices to be provided; \n \n17/ The Service manages pharmaceuticals \ndonated by international Organizations \nor other donors, in accordance with the \ndirective issued by the Ministry; \n \n18/ It facilitates the situation of working with \na third party by conducting a study and \nidentifying those activities better be \nperformed by private organizations from \nthe point of view of achieving better \nefficiency and economic benefit; \n \n19/ \nIt \nworks \ntogether \nwith \nlocal \npharmaceuticals manufacturers and other \nprivate organizations of the sector In a \nstrategical partner, based on the Law, and \nGuidelines that governs public-private \npartnership; \n \n \n \n20/ Cooperate and work with International, \nContinental, and National Organizations \nand stakeholders that work in areas \nrelated to the attainment of the Service’s \nobjectives; \n \n21/ It collaborates with relevant bodies at all \nlevels, including the Ministry, Regional \nGovernments and health facilities, to \nensure availability of pharmaceuticals; \n \n22/ It re-packs pharmaceuticals for the \npurpose of dividing and exporting the \njointly procured items to the countries \nthat take part in the agreement of pooled \nprocurement; by taking into account the \nadvanatages obtained from the economy \nof scale or for the sake of convenience \nand effectiveness of the health services \nto be provided locally; \n \n23/ Persuant to the board of management \napproval, the Service will determine the \namount and mode of payment in which \nthe expenses incurred in connection with \nthe procurement, storage and distribution \nof the Service, will be reimbursed by \nthose seeking the services; \n \n \n24/ Advises the Minister on issues related to \npharmaceutical \nsupply \nchain \nand \nlogistics;  \n \n780K2°£ \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17897 \n \nx{/ \n\u00019$jG\u0006 \n]\u0018\u0006O( \n\u0006MD \nBC \nq*?\u0015@A\u0003 ( \u0001^_ 9:;<R  \u001aW(l \n\u001aBEXsl \u001eY! \u001aq%> dC \u000bY rm\u0003 \ns\u0006Xq\u0003 \nq\u0002\u0003\u0004\u0005\u0006 \n\u0001!@\u0013 \nBC \n9:;<\u0003 \n%M[\u0015\u0019E \nBC \nqA  \nqG9MqNO( \n*\u001f\u000b\u0003 \n\u0017\" \n\u001a9^E \n\u0006X\u001e@m\u0015` \u001aA  \u001dF'\u0003! \u0001'X\u001e?: \n*?\u0015@A\u0003 BE\rW. \u0010$\u0001=! *XD\u000b](E \n\u000fh\u0006 \n\u001a'XqD\u0015 \n*?\u0015@AaE \nYW\u0019\u0015 \n\u001c\"\u001c­ \u001a99\u0011\u0006 Y?MÅ\u0015` \n \nx£/ \u001af *Ej¯ E¿X *Ej¯ (x{) \u0001\u001d?M¤( \nBE\t\u001d$\u001aj \n^e \n*?\u0015@Aa \nMA  \n\u001dF'\u0003 MGW$( \u0001'X\u001e?: *?\u0015@A\u0003 \n\u0001G\u0006XqhM( N\u0011h \u001a99\u0011\u0006 Y\u001eWC\u0015` \n \n \nx8/ \n.=! \n\u0001'YW® \nE\u0013PR E \n\u001a\u0006b \n\u001a'X\u001e?: \u0001G?S ?>E \u001e\t *?\u0015@Aa \n\u0001¾s\u0013 F\u0003 BE\r?% \u0006\t\"\u0017\u0015` \n \n \nxK/ \u0001E\u0013P\u0003 %M#\u0003 BC \u0001YÇN %M9\u0013\u0003 \nY^C\u0015l \u001a\n  X! Yqs\u0015l YqWs\u0015` \n \nxy/ \n\\\u000b'(E \nM'XDÈ! \n\u0001GP¡ \nA  \n\u001d\u0006\u0006o \u001d@%\n\u0003E! \u0006qC(C\u0015 \n \n7/\n7/\n7/\n7/. \n. . \n. \u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa *\tP±\u0003\n*\tP±\u0003\n*\tP±\u0003\n*\tP±\u0003  \n \n*?\u0015@Aa- \n \n \n// \u0001X\n *9\n\" Z\": (qf \u001a·\u000b “Z\":” \nB\u0001\u001d%M \u0001G$\n)` \n \n \n6/ \u001aG<X\u0003­   *=\n>\u0016\u0003   \u001a$=\u000bY   G<X\u0003­ \n\u0001GÉ!   +C   mY»\u000f\u001d\"   BC   !\u000f\u0003\u0015 +C \nmY»\u000f\u001dp ` BC   \n \n \n1/ *XD\u000b] \u0001^_ Q\n\u001dÊ ` \n \n \n \nYe­N\u0015 \n \n76\n76\n76\n76. \n. . \n. XM\nXM\nXM\nXM Z\":\nZ\":\nZ\":\nZ\": *%\u000b\u0003\n*%\u000b\u0003\n*%\u000b\u0003\n*%\u000b\u0003 *W\u0006\u0001!\n*W\u0006\u0001!\n*W\u0006\u0001!\n*W\u0006\u0001! BC\nBC\nBC\nBC \u0001[\n\u0001[\n\u0001[\n\u0001[\n T9E\nT9E\nT9E\nT9E \n \n// \u0001Z\"¡ W\u0013s> BC *%\u000b\u0003 \u001aG<X\u0003­ \n*=\n>\u0016\u0003 \u001a$=\u000bY G<X\u0003­ YÉ' \n \n \n6/ \u0001Z\"¡ *%\u000b\u0003 q\u0002\b\u0011 \u0001\u001b\u001c\u0013 \u001d\u001e\u001f\u0004  \n!\u000f\" #\u0003` qdC` qcYCEX` qA,XÄ\u000f` \nq\u001b@` q\u000f\u0015\u0015 dC T\"h \u0001G9\tg 4 \n*%\u000b\u0003E !p \u0013NO( 7/ Y^C\u0015  \n \n \n \n \n25/ The Service devises a mechanism for \nproper and timely disposal of expired \npharmaceuticals or medical by-products, \nwithout causing harm to human, animal, \nor environmental health together with \nEthiopian Food and Drug Authority and \nother relevant stakeholders. The details \nshall be specified in the Directive; \n \n \n \n \n26/  Subject to what is stated in Sub-Article \n(25) of this Article, the tariff charged by \nthe \nService \nfor \ndisposal \nservices \nprovided to other institutions shall be \ndetermined by the Directive; \n \n27/ The proceeds from the disposal of assets, \nwhich are no more beneficial for the \norganization, will be credited to the \naccount of the Service; \n \n28/ Own and possess property, enter into \ncontracts, sue and be sued in its name; \n \n29/ Perform other related activities as may be \nnecessary for the attainment of its \nobjectives. \n \n11.  Organization of the Service \n \nThe Service shall have: \n \n1/ Board of Management (hereinafter referred \nto as \"Board\"); \n \n2/  A Director General and Deputy Director \nGenerals, to be appointed by the Prime \nMinister based on the recommendation \nof the Minister; and \n \n3/  The necessary staff. \n \n \n12. Appointment of Board Members and their \nTerms of Service \n \n1/ The Chairperson and members of the \nBoard are appointed by the Prime \nMinister based on the recommendation \nof the Minister. \n \n2/  The Board shall be comprised from the \nHouse \nof \nPeoples' \nRepresentatives, \nHealth, Finance, Logistics, Justice; and \nthe number of members shall be 11 \nincluding four members to be appointed \nfrom Regional Health Sector.  \n  \n \n \n \n780K2°8 \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17898 \n \n1/ \u0001*?\u0015@Aa +C mY»\u000f\u001d\" \u0001Z\"¡ *%\u0015 BC \n¤² Y^C\u0015 \n \n \n \n4/ \u0001Z\"¡ *%\u000b\u0003 \u0001[\n T9E X\u0003 \\9\u0003 \n\u0010^El BE\t*XD\u000b]\u0016a M\u001d'\u0011 *E: \n\u0001[\n T9E \n\u0014\nT! Y \u000b\u0015` \n\u0001\u000f\u0015A  \n(\u000f\u0015C \u001aÆ\" Y^C\u0015 \n \n \n \n{/ G<X­ MZ\": *%\u000b\u0003 \u0001GqDM(E *\u001a\u0015 \n!p \n\u0001Z\"¡E \n*$V\u000bY \n*W\n\" \n\u001aG9Mq\u0003 \n\u001c\"\u001c\" \n\u0001*W\n\" \n99\u0011\u0006 \n\u0006\u001e\u0019\u0015 \n \n \n71\n71\n71\n71. \n. . \n. \u0001Z\"¡\n\u0001Z\"¡\n\u0001Z\"¡\n\u0001Z\"¡ [\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC \u001d@%\"\n\u001d@%\"\n\u001d@%\"\n\u001d@%\" \n \nZ\"¡ \n\u0001Gq\u001d\u0003 \nX\u0015\u0019EC \n\u001d@%\n\u0003 \nYe­N\u0015- \n \n// \n\u0001fE \n*+, \n*DÅ¤!C \n*?\u0015@AaE \n\u001a\u001a\u000bY\u0016\u0003 Y9\n\u0015` YÃ\u0019$\n\u0015` \n \n6/ \u0001*?\u0015@AaE \u0001P,!C *b\" ]\u0018 X\u0003\n\u000f \nt=Ë E 9\"!p \u0006¤:V\u0015` *DÅ¤E! \nYqN\u001d\u000b\u0015` \n \n \n1/ \u0001*?\u0015@AaE \\9N\f \u0001X\n 9\"i-@\u0013\"l \n\u001a\u0003 BE\rn! \u0001\u001f¥N\u0015 \u001e t=:E \n9\"!p \u0006¤:V\u0015` *DÅ¤E! YqN\u001d\u000b\u0015` \n \n \n4/   *?\u0015@Aa \u0001\u001dq'O v\u0013\u0003 \u0010eP( .C\u0003E \n9QP\u0003 \n\u001a':P@ \nqv\u0013a \n\u0001\u001d\u001eW\u0016(E \n?ET\u0013   \u0001@!±  #\u0003  W\u0016:  M9@\u0003 BE\r(\u0015\n \u0014\u001eXE Y \u000b\u0015` \n \n{/ \u0001*?\u0015@AaE \\\u000b' M's\u001f\u0003 \u0001G\u0006XD\u0015r \n\u0001\u001dM\u0006© \u0001*W\n\" 99\u0011\u0006 E \u0006¤:V\u0015` \n\u001aX\n \u000bY 9+\u000bO(E! YqN\u001d\u000b\u0015` \n \n£/ q9:;<\u0003 *=\"Z\u0003 *?\u0015@A\u0003 \u0001G?S \n\u0001\u0006b fm@E 9\"!p \u0006¤:V\u0015` \n \n8/ q9:;<\u0003 @o` \u000f! \u0003 BC [\"b\u0003 \u0017\" \n\u001a\u001d\u0006\u0006T  \u0001GqDM(E \u0001*?\u0015@A\u0003 \u000fh\u0006 \nY\u001eXC\u0015` \n \nK/ q*?\u0015@Aa \u001d@%\n\u0003 9\u001fq\u0015 \u001aX\u001du \u001e?E \nBE\rqC\u001e_ \n\u0001\u001dM© \nrm\u0004 E \n9\"!p \n\u0006¤:V\u0015` *DÅ¤E! YqN\u001d\u000b\u0015` \n \ny/ \n\u0001*?\u0015@Aa \n¾s\u0013 \n\u001a(b \nÌ\r\u001d\" \n99\"9­E \u0006P\u0017@\u0019\u0015` \n \n \n3/  The Director General of the Service will \nbe a member and a Secretary of the \nBoard. \n \n4/   The term of service of the members of the \nBoard is three years, and it can be \nextended for an additional one term as \ndeemed necessary; regions representation \nshall be inround \n \n5/  The Minister shall issue detailed operating \ninstructions \nregarding \nthe \ngeneral \noperation of the Board, including the \nallowances to be paid to the Board \nmembers. \n  \n13.  Powers and Duties of the Board \n \nThe Board shall have the following powers \nand duties:- \n \n1/  \nOversee \nand \nsupervises \nthe \nimplementation and execution of this \nProclamation \nand \nthe \nService \nrespectively; \n \n2/    Review and approves the long- and \nshort-term strategic plans of the Service; \nand monitors its implementation; \n \n \n3/  Review and approves the Service's annual \nwork \nplan, \nbudget \nand \ncapital \nexpenditure plan; and monitors its \nimplementation; \n \n4/    Based upon a well-studied investment \nplan, it decides on partial investment of \nthe \nService’s \naccumulated \nassets \nincluding on the purchase of treasury \nbills; \n \n5/ Endorses different operational guidelines \nrequired to achieve the purpose of the \nService; \nand \nmonitors \ntheir \nimplementation;  \n \n \n6/  Reviews and endorses sales margin from \nrendering phamaceuticals supply service; \n \n7/  It determines the service fee to be paid in \nrelation to procurement, storage and \ndistribution; \n \n8/ Reviews and approves those functions \nbetter be outsourced to a third party from \namong the functions of the Service and \nmonitor its implementation; \n \n9/ Ensures the account of Service are audited \nby an external Auditor; \n \n \n780K2°K \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17899 \n \n7/ \n\\9N\f \n\u0001¾s\u0013 \n\u0011Á\"\u0003E \n\u0006¤:V\u0015` \n\u0001(X.C \n\u0001(b \n\u0001Ì\r\u0003 \n\u0011Á\"R E \n\u0006m!\u0019\u0015` \u001a\u0011Á\"a 9QP\u0003 *XD\u000b]( \n\u0001B\"!\u0003 \nB\"!± \nBE\r\u001eW: \n\u0006\t\"\u0017\u0015l \n\u0011Á\"aE! MG9Mq\u001d( *\u001f\u0015 \u0006j\"%\u0015` \n \n7// *?\u0015@Aa *\rX =\"E)h BE\rqh\u0003 \n\u001eY! \u0016%\" =\"E)h  BE\rT\u0017 Y\u001eXC\u0015` \n \n76/ \u0001*?\u0015@AaE  \u0001X\n  ;\u000b E  =.\" l\n !\t% BC \nXE\u0013\u0003 \u001a+C \nmY»\u000f\u001d\" \n*=\n>\u0016\u0003 \u0006¤:V\u0015` \n \n71/ \u0001*?\u0015@AaE 9+=\n\f *\tP±\u0003 9\"!p \n\u0006¤:V\u0015` \n \n74/ \n*?\u0015@Aa \nqG\u0006qC(\u0016( \n\u00019:;<\u0003 \n*=\"Z\u0003 *?\u0015@A\u0003 \u001b\u0013P\u001dWg \u001d$VG \n9^_E \u0006P\u0017@\u0019\u0015` \n \n7{/ DE¡ M9:;<\u0003   @o   BC    M9:;<\u0003\n *=\"Z\u0003   *?\u0015@A\u0003 'Xc\u0006C '$Cq\u0011\u0006 \n9+E\u0006P\u0017@\u0019\u0015` \n \n7£/ \n\\\u000b'(E \nM'XD¤! \n\u0001G\u0006@Æ \nA  \n\u001d@%\n\u0003E! \u0006qC(C\u0015 \n \n74\n74\n74\n74. \n. . \n. \u0001Z\"¡\n\u0001Z\"¡\n\u0001Z\"¡\n\u0001Z\"¡ \u0001X\u0013W%\n\u0001X\u0013W%\n\u0001X\u0013W%\n\u0001X\u0013W% [\u0016\n[\u0016\n[\u0016\n[\u0016-[\"\\\u0003\n[\"\\\u0003\n[\"\\\u0003\n[\"\\\u0003 \n \n// Z\"¡ \u001a\u001e\" *E: ]\u0018 9\t\u001au X\u0013W% \n\u0006\u001f¾m\u0015` ^e! \u001aZ\"¡ W\u0013s> (s \n\u001eY! qZ\": *%\u000b\u0003 >\u0006EX *E: X\u001du \n\u0006f *XOÍY X\u0013W% BE\r$\n q$\u0001- \nZ\"¡ \u001a'Eu(! ]\u0018 *XOÍY X\u0013W% \n\u0014\u0006\u001f¾: Y \u000b\u0015 \n \n6/  \u001a'CO(! X\u0013W% q*%\u000ba q@' \u001a\u000bY \n\u0001G^_\u0003 q\u001d? !\u0015\\\u001d-r%Î Y^C\u0015 \n \n1/ \u0001Z\": *%\u000b\u0003 \u001a\u001dM 9$E (s E \n\u001aX!!\u0016\u0003 \u0006s\u0015c` ^e! X!!\u0016\u0003 \u000bY \n9:PX \u001f\u0015 \u001a:!¯ \u0013\u0015) Y\u001eXC` \n:!¯ tU\u0015 \u001aG^E\u001a\u0003 ]\u0018 \u0001Z\"¡ W\u0013s> \n\u001esS :!¯ YeP+\u0015 \n \n4/ 'Eu(! \u0001\u001dM\u0001 \u0001(s ;s\u0013 \u0006M( *%\u0015 \n;sg \u001a\u0015©\u0016\u0003 BE\r\u0006\u001cM\u0003 q$\u0001j \u0001\u0015©\u0016\u0003 \n;sg \n\u001a(s( \nVM-r%Î \nBE\r\u001f\u001d\u0003 \nY\tP\u0017\u0015 \n \n{/ \u0001f *Ej¯ :E\u0017Ï BE\t\u001d$\u001aj ^e Z\"¡ \n\u0001\n E \n\u0001X\u0013W% \n[\u0016-[\"\\\u0003 \n99\u0011\u0006 \n\u0014\u0006\u001e\u0019 Y \u000b\u0015   \n \n10/ Endorses the annual financial report; \nlistens to internal and external audit \nreports; \nand \ntakes \nthe \nnecessary \ncorrective measures and submits the \nreport to the appropriate body; \n \n11/ Decides the opening of a new branch or \nthe closure of an existing branch by the \nService; \n \n12/ Approves the hiring, assignment and \ntermination of the Service's Officials on \nthe recommendation of the Director \nGeneral; \n \n13/ Approves the organizational structure of \nthe Service; \n \n14/ Ensures that the community benefits from \nthe pharmaceutical supply of the Service; \n \n \n15/ Ensures that the fund is used for the \nexpansion and strengthening of drug \nprocurement and drug supply services; \n \n16/ Perform other related activities as may be \nnecessary for the attainment of its \nobjectives. \n \n14.  Meeting Procedure of the Board \n \n1/ The Board shall meet once every month; \nhowever, the Chairperson or one-third of \nthe members may summon extraordinary \nmeetings at any time. \n \n \n \n2/   There shall be a quorum where more than \nhalf of the board members are present in \na meeting. \n \n3/ Board members pass decisions by \nconsensus \nto \nthe \nextent \npossible; \nhowever, \nif \nthey \ncannot \nreach \na \nconsensus, they will decide by majority \nvote; In the event of a tie, the chairperson \nof the board will have a casting vote. \n \n4/ If any member on the Board with a \ndifferent opinion request that the opinion \nbe recorded as a difference, the different \nopinion will be included in the minutes \nof the Board’s Decision. \n \n5/    Without prejudice to the provision of this \nArticle, the Board may issue its own \nmeeting procedure guidelines. \n \n780K2°y \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17900 \n \n7{\n7{\n7{\n7{. \n. . \n. qZ\":\nqZ\":\nqZ\":\nqZ\": *%\u0015\u0016\u0003\n*%\u0015\u0016\u0003\n*%\u0015\u0016\u0003\n*%\u0015\u0016\u0003 XM9WC\u001a\u0003\nXM9WC\u001a\u0003\nXM9WC\u001a\u0003\nXM9WC\u001a\u0003 \n \n// W\u0013s>(E !p 'CO(! \u0001Z\": *%\u0015 \n\u0001*E: \u001e\" \u0001=:9 9\u0015j&\u0006 '9\u0015q \n\u001a'=P\u0013 \n \nqZ\": \n*%\u0015\u0016\u0003 \n9\u0015j= \nY \u000b\u0015 \n \n6/ \n'Eu(! \n\u0001Z\": \n*%\u0015 \nqGq\u001d\u0003 \n!\u000fE\u0006R  \n\u001a*E¡ \nq*%\u0015\u0016\u0003 \n\u0014WC\u001a\u0003 \nY \u000b\u0015- \n \n v)    \u001adC \n @\" \n!\u000fE\u0006\u0003 \n;\u000b\u0016aE \n9\u001e\u0019\u0003 \u001f\u0015M` \n \nM)   \u001a\u001eE\u0015 \u001dq .c\u001du\u0016a \u001ah\": #\u0003 \nq\u001dP\u0017?$` \n \n \n²) q%: \u0001[\u0016-!@%\" \u001eY! \u0001\rX\u0014E \nr:M\u0003 q\u001d?¶\u001a\u0003` \n \n9) \u0001\u001dW$(E ;\u000b\u0016\u0003 \u001a*@%g \u001f\u0015\u001d\u001e\u0019 \n\u001eY! \u0006M \u001a& !\u000fE\u0006\u0003 \u001a\u001dqNNY \nqÀX\u0003 ]\u0018 \u001a\u000bY \u001aZ\"¡ X\u0013W%  \n\u000bY \u001f\u0015\u001d?¶ \n \n1/ \u001a\u001dM\u0006\u0001 !\u000fE\u0006\u0003 \u0001Z\": *%\u000b\u0003 -.\" \n\u0010\t\u0015 G<X\u0003­ \u001a1 \u001e\" ]\u0018 (X. \n\u001a\tM( \n*%\u0015 \n!\u0003\u000f \n\u001d\u001dÐ \n*%\u0015 \nBE\r9\t\u0013 \u0006\t\"\u0017\u0015 \n \n4/  \u001af *Ej¯ E¿X *Ej¯ (/) BC E¿X \n*Ej¯ (6) X\" q\u001d$j \u0003 !\u000fE\u0006R  \n\u001a*E¡ qZ\": *%\u0015\u0016\u0003 \u001a\u001dWC\u001a\u001d *%\u0015 \n!\u0003\u000f \u0001G9\t\u0013 \u0001Z\": *%\u0015 M\u001d'\u0011 \n\u0001X\n T9E BE\rW\n \u001f\u0015\u001d9\t\u001a \u001aX\u001dj\" \n\u0001*?\u0015@A\u0003 T9_ \u001a\u001d\u001dÐ\u0016\u0003 q\u001d9\t\u001a\u001a\u0003 \nZ\": \u0001X\n T9E \u0014\u001a\u0015. *Y \u0015! \n  \n \n    \n7£\n7£\n7£\n7£. \n. . \n. \u0001.=!\n\u0001.=!\n\u0001.=!\n\u0001.=! @b\u0003E\n@b\u0003E\n@b\u0003E\n@b\u0003E \u0001's\u001e=\n\u0001's\u001e=\n\u0001's\u001e=\n\u0001's\u001e= @N\n@N\n@N\n@N \n \n'Eu(! \u0001Z\": *%\u0015 \u001aZ\"¡ (X. \u001fM( \n[\n \u0017\" \u001aj.N! ^\u0016 \u001a\u001dT++\u0011 \u0001.=! \n@b\u0003 \u0010\u0006\u0017.9( YfE_ MZ\"¡ \u001a's\u001e= \nrm© qGNY%O( \u0001Z\"¡ X\u0013W%  n \n\n E '@M\u0015 *M\u001a\u0003 \n \n  \n78\n78\n78\n78. \n. . \n. \u0001+C\n\u0001+C\n\u0001+C\n\u0001+C mY»\u000f\u001d­\nmY»\u000f\u001d­\nmY»\u000f\u001d­\nmY»\u000f\u001d­ [\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC\n[\u0015\u0019EC ;\u000b\u0016\u0003\n;\u000b\u0016\u0003\n;\u000b\u0016\u0003\n;\u000b\u0016\u0003 \n \n//   +C \nmY»\u000f\u001d­ \n\u0001*?\u0015@AaE \nX\n  \nY9\n\u0015l \u0006X\u001dm:\n\u0015 \n \n6/ \u0001f *EjJ E¿X-*EjJ (/) *$V\u000bY \n:E\u0017Ï BE\t\u001d$\u001aj ^e +C mY»\u000f\u001d­-  \n \n15.  Dismissal  from Board Membership \n \n1/ Any member of the Board, including the \nChairperson, can resign at any time by \nsubmitting one month prior notice of \nresignation. \n \n2/  Board members may be dismissed from \nmembership for one of the following \nreasons: \n \na) If he is unable to fulfill his \nresponsibilities \ndue \nto \nhealth \nproblems; \n \nb) If he is accused of a criminal offense \nand found guilty by the court’s \ndecision; \n \nc) If he is committed a serious moral or \ndisciplinary offense; \n \nd) If he fails to perform his assigned \nresponsibility properly or if he fails \nto attend on three consecutive board \nmeetings. \n \n3/  When the number of Board members is \nreduced due to various reasons, the \nMinister must appoint a substitute \nmember in place of a missing member \nwithin 3 months. \n \n4/   Unless a board member, who is appointed \nto replace a member who resigns from \nthe board due to one of the reasons \nmentioned on Sub-Article (1) and (2) of \nthis Article, is re-assigned to work for an \nadditional term, his term of service \ncannot exceed the term of office of the \nboard to which he will be assigned as a \nreplacement. \n \n16. An Obligation to Disclose Conflict of \nInterest \n \nAny member of the board who has a direct or \nindirect conflict of interest with his work in \nthe board must notify the Board and excuse \nhimself from all board meetings where the \nmatter is discussed. \n \n17. Powers and Responsibilities of the Director \nGeneral \n \n1/ The Director General shall direct and \nadminister the activities of the Service. \n \n2/ Without prejudice to the general provisions \nof Sub-Article (1) of this Article, the \nDirector General shall have the following \nresponsibilities: \n780y2\n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17901 \n \nv) \n\u001af *+, *EjJ 7 \u0001\u001d9Mqa\u0003E \n\u0001*?\u0015@AaE X\u0015\u0019EC \u001d@%\n\u0003 \u001aX\n \n\u000bY \u0006(\u000b\u0015` \n \nM)  \u0001G<X\u0003p  !\u000f\" #\u0003 \u001aG\u0006\u001e\u0019( \n\tE\u0013 9QP\u0003 \u0001*?\u0015@AaE Q\n\u001dÊ  \n\u0006X\u001dm:\n\u0015` \n \n²) \u0001*?\u0015@AaE *\tP±\u0003 \u001a'X$C\u0003 \nMZ\": \n*=\"Z \n\u0006¤:V\u0015`\u001d@%\n\f! \n\u0006\t\"\u0017\u0015` \n \n9) \u0001*?\u0015@AaE \\9N\f \u0001X\n p@\n! \nBC \u001a\u0003 *T\u0017,R MZ\"¡ \u0006j\"%\u0015l \n\u0010Dj:! \u001aX\n \u000bY \u0006(\u000b\u0015l \u001a\u0001­\u0013 \n\\9a \u0001t=: *DÅ¤! \u0011Á\"\u0003 MZ\"¡ \n\u0006j\"%\u0015` \n \nQ) \u0001*?\u0015@AaE \u0001%E\u000f ¾s\u0013 YqhN\u0015l \n\u0006Ejs=s\u0015` \n \nP) \u0001*?\u0015@Aa \u0001¾s\u0013 9\u001c?\u0013 \u001a*@%g \n9\u0006ÆE YqN\u001d\u000b\u0015` \n \nW) qX\u001du \n\u001e?e  \n\u0017\" \n\u001aG\tPr \n@E\u0016R  *?\u0015@AaE Y\u001e\u000f\u000b\u0015`  \n \n \nª)    +C mY»\u000f\u001d­ [\nE M'j\u000b$h \\\u000b' \nqX\u0015\u0019EC ;\u000b\u0016a \u001aq\u0015 M*?\u0015@Aa \n!\u000f\u0003\u0015 +C mY»\u000f\u001dp  BC MA  \nQ\n\u001dÊ  \n\u001a(\u000f\u0015C \n\u0014\u0006X\u001d\u000b\u0015h \nY \u000b\u0015` \n \n \n \nj) qZ\"¡ \n\u0001GW®\u0003E \nA  \n\u001d', \n\u001d@%\n\u0003 \u0006qC(C\u0015 \n \n \n7K\n7K\n7K\n7K. \u0001!\u000f\u0003\u0015\n\u0001!\u000f\u0003\u0015\n\u0001!\u000f\u0003\u0015\n\u0001!\u000f\u0003\u0015 +C\n+C\n+C\n+C mY»\u000f\u001d\"\nmY»\u000f\u001d\"\nmY»\u000f\u001d\"\nmY»\u000f\u001d\" \u001d@%\"C\n\u001d@%\"C\n\u001d@%\"C\n\u001d@%\"C ;\u000b\u0016\u0003\n;\u000b\u0016\u0003\n;\u000b\u0016\u0003\n;\u000b\u0016\u0003 \n \n\u0001*?\u0015@Aa !\u000f\u0003\u0015 +C mY»\u000f\u001d\"- \n \n//  \u0001*?\u0015@AaE \u001d@%\n\u0003 \n\u001a'j:` \n\u001a'\t\n\u0003` \u001a9!\n\u0003C   \u001a'X\u001d%\u001a\" +C \nmY»\u000f\u001d­E \u0006@` \n \n6/ \u001a+C  mY»\u000f\u001d­  \u001dMYR  \u0001GW\u0019O(E  \nA   \u0001*?\u0015@AaE  \u001d@%\"C  ;\u000b\u0016R  \n\u0006qC(C` \n \n1/ \u0001*?\u0015@Aa +C mY»\u000f\u001d­ \u001a\u001dM\u0001 nN \n\u001f\u0015\u001eqM \u001aX\u001dj\" \u001aÑ9\u0003 j\t!\u0003\u0016\u0003 \u0006MÒ\n !\u000f\u0003\u0015 +C mY»\u000f\u001d\" +C mY»\u000f\u001d­E \n\u001e\u000fA YW\n\u0015 \n \n \na) Exercise the powers and duties of \nthe Service specified under Article \n10 of this Proclamation; \n \nb) Manages the employees of the \nService, in accordance with the \nRegulation issued by the Council of \nMinisters; \n \nc) Implements \nthe \nproposed \ngovernance structure of the Service, \nupon approval by the Board; \n \nd) Prepare and submit to the Board the \nannual work plan and budget of the \nService and implement the same \nupon approval; he shall also submit \nthe performance report of the \nService to the Board quarterly; \n \ne) Opens and operates the Service’s \nbank account; \n \nf) \nOversees the Service's books of \naccounts; \n \ng) Represent the Service in all its \ndealings with third parties; \n \nh) The Director General may delegate \npart of his powers and duties to the \nDeputy \nDirector \nGenerals \nand \nemployees of the Service to the \nextent necessary for the effective \nmanagement of the functions of the \nService; \n \n \ni) \nPerform other duties assigned to him \nby the Board. \n \n \n18.  Powers and Duties of Deputy Director \n \nThe Deputy Director Generals shall: \n \n1/   Assist the Director General in planning, \norganizing, directing and coordinating \nthe activities of the Service; \n \n \n2/    Perform other duties and  responsibilities\n of   the  Service   as   assigned   by  the \nDirector General; \n \n3/   In the absence of the Director General of \nthe Service, unless the Director General \ndesignates one of the Deputy Director \nGenerals, a Senior Deputy Director \nGeneral acts on behalf of the Director \nGeneral. \n \n \n \n780y2/ \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17902 \n \n7y\n7y\n7y\n7y. \n. . \n. \u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa\n\u0001*?\u0015@Aa \u001a\u0003\n\u001a\u0003\n\u001a\u0003\n\u001a\u0003 BC\nBC\nBC\nBC \u0001\u001a\u0003\n\u0001\u001a\u0003\n\u0001\u001a\u0003\n\u0001\u001a\u0003 \\9\u0003\n\\9\u0003\n\\9\u0003\n\\9\u0003 \n \n    \n// \u0001*?\u0015@Aa   \u001a\u0003   \u0001GªD\u0016(  \u001af *+, \n*Ej¯  4  X\"  q\u001dTPT­\u0003  \u0001DE:  !E´  \nqGW\u001aW\u0013 ?> \u0016( \n \n6/ \u0001*?\u0015@Aa \u001a\u0003 \\9\u0003 \u0001\b\t\n\u0015 9E@Xa \n\u0001\u001a\u0003 \\9\u0003 Y^C\u0015 \n \nx. \n. . \n. XM\nXM\nXM\nXM \u000fh\u0006\n\u000fh\u0006\n\u000fh\u0006\n\u000fh\u0006 \n \n//  \u0001*?\u0015@Aa  'Eu(! ?ET\u0013 \u001e \n^e \n\u0001GqDM(  M*?\u0015@Aa   \u001a¤\tj( \\9N\f \n\u0001X\n p@\n! 9QP\u0003 Y^C\u0015 \n \n6/ \u001af *EjJ E¿X *EjJ (/) \u0001\u001d?MÈ( \nBE\t\u001d$\u001aj ^e Z\"¡ \u001c\"\u001c\" \u0001\u000fh\u0006 \n*DÓÈ! 99\u0011\u0006 \u0006\u001e\u0019\u0015 \n \n \n1/ \u0001f *Ej¯ E/*Ej¯ (/) :E\u0017Ï >e\"! \n\u001a*?\u0015@Aa \\9N\f \u0001[\n t=: (X. \n\u0006\u0015\u001d\u001f\u001da \u001eY! qW( W\nC \u001dD.\f \n\u000fX\u001dR  \u0017\" \u0001\u001d\u0006\u0006Æ :E?\u001du *\t\u0017  \n\u0010\u0006\u0017. \n\u001a*?\u0015@Aa \n[\n \n*XDÅG \nG (s \u000fh\u0006 \u0014D¤! Y \u000b\u0015 \n \n    \n  \nx/\nx/\nx/\nx/. \n. . \n. XM\nXM\nXM\nXM ¾s\u0013\n¾s\u0013\n¾s\u0013\n¾s\u0013 9@\u0013\u0003\n9@\u0013\u0003\n9@\u0013\u0003\n9@\u0013\u0003 BC\nBC\nBC\nBC Ì\r\u0003\nÌ\r\u0003\nÌ\r\u0003\nÌ\r\u0003 \n \n// *?\u0015@Aa \u0001\u001d§\u000bC \u0003\u000f\u000fMu \u0001^_ \u0001¾s\u0013 \n9@\u0013\u0003E YY\u0015 \n \n6/ \u0001*?\u0015@Aa \u0001%E\u000f ¾s\u0013 \u001a\u0019!\n \"' \nYqDN\u0015 ` YEjsjs\u0015 \n \n1/ +C mY»\u000f\u001d\" \u0001\u001a\u0003 \\9a \u001a\u001d$Cjj \n\u001aX\u0003 \u001e\n\u0003 ]\u0018 (X. \u0001¾s\u0013 9@M)El \n\u0001+C  +C  *DÅ¤!  *9\u0015\u001fw E  BC \u001d', \n9P± E \u0001\u0006T \\9N\f \u0011Á\"\u0003 MZ\"¡ \n*=\"Z \u001a'È\t= MG<X­ \u0006j\"%\u0015 \n \n \n4/  \u0001*?\u0015@Aa \u0001¾s\u0013 9@\u0013\u0003 BC ?ET\u0013 \u0016\u000f \nW\u0016Ë  \u001a\u0001\\9a \u001a+C Ì\r\u001d\" \u001eY! B\"  \n\u001aG\u001e\u000fM( Ì\r\u001d\" Y9P9\n:: \u001aÌ\r\u001d\" \n\u0001\u001d9P9­ \u0001¾s\u0013 9@M)  MZ\"¡ \nYj\"% \n \n \n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015\n\u000fh\u0015 *\n\u0003\n*\n\u0003\n*\n\u0003\n*\n\u0003 \n \n\u0015©\n\u0015©\n\u0015©\n\u0015© \u0015©\n\u0015©\n\u0015©\n\u0015© :E\u0017Ï \n:E\u0017Ï \n:E\u0017Ï \n:E\u0017Ï  \n \nx6\nx6\nx6\nx6. \n. . \n. \u0001W(\n\u0001W(\n\u0001W(\n\u0001W( ;\u0013\u0003\n;\u0013\u0003\n;\u0013\u0003\n;\u0013\u0003 *X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\" \n \n\u0001*?\u0015@Aa  \u0001W( ;\u0013\u0003  *X\u001dm\t\"  \u001aG<X\u0003p  \n!\u000f\" #\u0003 \u001aG\u001e\u0019 \tE\u0013 Y\u001eWC\u0015 \n \n19.  Budget of the Service and Fiscal Year \n \n \n1/  The budget of the Service shall be covered \nby the revenue obtained from source of \nfunds stipulated on Article (4) of this \nProclamation. \n \n2/  The fiscal year of the Service shall be the \nfiscal year of the Federal Government. \n \n20.  Disbursement \n \n1/   Disbursement of the pharmaceutical fund \nshall only be made in accordance with \nthe approved work plan of the Service. \n \n2/  Without prejudice to Sub-Article (1) of \nthis Article, the Board will issue detailed \npayment guideline. \n \n3/   Despite Sub-Article (1) of this Article, \npayment may be made based on the \ndecision of Executive Committee, when \nthere are tasks that are not included in \nthe annual work plan of the Service and \nemergencies associated with man-made \nor natural disasters, \n \n21.  Books of Accounts and Audit \n \n1/ The Service shall keep complete and \naccurate books of accounts. \n \n2/   The Service bank account shall open and \noperate with joint signature. \n \n3/  The Director-General shall submit annual \nreport containing financial statements, \nkey performance indicators and related \ninformation to the board approval and \nsubmits the approved report to the \nMinister. \n \n4/ The accounting records and financial \ndocuments of the Service will be audited \nannually by External Auditors and \naudited financial statements will be \npresented to the Board. \n \n \nPART FOUR \n \n \nMISCELLANEOUS PROVISIONS \n \n22.  Human Resource Management \n \nThe Human Resource Management issues \nshall be determined by the Regulation issued \nby the Council of mMnisters. \n \n780y26\n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17903 \n \nx1\nx1\nx1\nx1. \n. . \n. \u0001tm\n\u0001tm\n\u0001tm\n\u0001tm \u000fh\u0006\n\u000fh\u0006\n\u000fh\u0006\n\u000fh\u0006 *X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\"\n*X\u001dm\t\" \n \n    \n// \n/ / \n/ *?\u0015@Aa \u001a¡# \u000bW\n)O( 9:i<R  \n\u0001dC \u001dF \u001d?>(E \u000fh\u0006 sYqh\u0015 q£ \n\u001e\" \u001a\u000bY qÃ\u0001 BC dC \u001dF q*?\u0015@Aa \n\u0017\" \u001aG?%( (\u0015 9QP\u0003 tm(E \u001a\u001e=a \nsYqh\u0015 qjP \u001aj.N q%E\u000f ¾sg \u000bY \nBE\tGj\u0016X X!!\u0016\u0003 \u000bY \u001d\t\" q^\u0016 dC \n\u001dF \u001a%E\u000f \u001fM( ¾s\u0013 \u000bY \u001djE \u001e\t \n*?\u0015@Aa ¾s\u0013 ?> Y\tP\u0017\u0015` \n \n \n6/  \u0001fE *EjJ E¿X-*EjJ (/) \u001d@%\n\f \nM':P@ 'Eu(! %E\u000f \u001eY! \u0001cYCEX \n\u001dF! \u001a*?\u0015@Aa \u0010$\u0001= 9qD\u0015 \u0006M\u001a\u0003E \n?ET\u0013 \n\u0006M!E! \n=:9 \nnN \n\u0001\u000fh\u0006 \n@N(E \u001f\u0015\u001d\u001e\u0019( \u0001dC \u001dF! ¾s\u0013 \n\u000bY \njE \n\u001e\t \n*?\u0015@Aa \n¾s\u0013 \n?> \n\u0001':P@ @N *M\u001a\u0003 \n \n1/ 'Eu(! %E\u000f \u001eY! \u0001cYCEX \u001dF! \nqdC \u001dF ¾s\u0013 \u000bY jE \u001a*?\u0015@Aa \n¾s\u0013 \n?> \nBE\r\u0006\t\"@ \n\u001a¯nh \n\u0003t\u001c \nq\u001dW$( \u001a·\u000b M*?\u0015@Aa 9qD\u0015 \u0006M\u001a\u0003 \n¾s\u0013 \u001djC q9\tPr \u001a\u0003 qdC \u001dF \n¾s\u0013 ?ET\u0013 \u001e *:\" >?S %EU \u001eY! \n\u0001cYCEX \u001dF \u001e BE\r\tP@ \u001aDj\t( \n\u0001?ET\u0013 9$E \u0015\u000f \u001d$\u0006& BC ;\u000b \nY^C\u0015 \n \n \n4/ \u001af *Ej¯ qE¿X *Ej¯ (/) BXq (1) \n\u0001\u001d\t\u0016??( >e\"! tm( \u001aj.N qdC \n\u001dF \u0001%E\u000f ¾s\u0013 \u000bY \u001djC 9\tPr \ndC \u001dFE 9\t\u001au \u0001dC *?\u0015@A\u0003 \n9X$\u0003 \n\u0001'Y \u0015\u001a\u0003 \n\tP± \n\u000bY \n\u0001G\u0006\t\"W( 9^_ \u001eY! \u001a¡# \u0001\u001d?( \n9:i<\u0003 \u001aX\n \u000bY \u0001+M( *Xj:9( \n\u0014Nj¡ \u001a'Y  W( W\n BC \u001dD.\f \n:E?\u001du \n*\t\u0017  \n\u0001\u001dD$PE \n\u000fX\u001d\u0003 \nM9q\u000bq\u0015 \u001eY! M'q! \\\u000b' 9^_ \n\u001aG<X­ \u001eY! \u001a\u000f\u0015\u0015 dC >p  \n\u0010P\u0017?. BE\t*@%\u0013\u0016a tm( \u001aG<X­ l \n\u001a?ET\u0013 G<X\" \u001eY! \u001a\u000f\u0015\u0015 cYCEX \n>p  \n*'\u001fS\u0016\u0003 \nBE\rqD\u0015 \n9\tP@ \nYe\"\u001aN\u0015 \n \n \n \nx4\nx4\nx4\nx4. \n. . \n. \u001a9:;<\u0003 *=\"Z\u0003 Æ\u0011\u0006 \u0001dC \u001dF'\u0003 \n\u001a9:;<\u0003 *=\"Z\u0003 Æ\u0011\u0006 \u0001dC \u001dF'\u0003 \n\u001a9:;<\u0003 *=\"Z\u0003 Æ\u0011\u0006 \u0001dC \u001dF'\u0003 \n\u001a9:;<\u0003 *=\"Z\u0003 Æ\u0011\u0006 \u0001dC \u001dF'\u0003 \nBC  \u0001*?\u0015@Aa @N\nBC  \u0001*?\u0015@Aa @N\nBC  \u0001*?\u0015@Aa @N\nBC  \u0001*?\u0015@Aa @N \n// \u00019E@X\u0003 dC \u001dF'\u0003 \u001a \u00019QPN\f \n9:;<R  \u0001*=\"Z\u0003 h\u000bNO(E \u001aj.N \nM*?\u0015@Aa \u0013 .\u0006¢ \u001a'=P\u0013 Y?M?\u000b` \n*?\u0015@Aa \n\u0001\u001d$\u0001-\u0003E \n9:;<R  \nM'=P\u0013 \u001a'Y \u0015\u001a\u0003 \u001e=\u0003 MdC \u001dF'a \n\u001d?>(E  \u00019h\u0003Õ *'\nb YW\u0019\u0015  \n23.  Debt  Payment Administration \n \n1/  If the health facility fails to pay its debts \nfor \nover \nsix \nmonths \nfor \nthe \npharmaceuticals it had received on a \ncredit basis, the Service has a right to get \nthe debts amount deducted from the \nhealth \nfacility’s \nbank \naccount, \nin \naccordance to the agreement conducted \nby the two parties. \n \n \n \n2/ To implement Sub-Article (1) of this \nArticle, any bank or financial institution, \nwhen requested by the Service, is obliged \nto deduct the amount without any pre-\ncondition from the health facility’s \naccount and deposit the money to the \naccount of the Service. \n \n3/  If money is found to be withdrawn from \nthe health facility’s account before the \nbank or the financial institution deposit \nthe deductible amount to the Service’s \nbank account after it received the written \nnotice from the Service, the bank or the \nfinancial \ninstitution \nwill \nbe \nheld \nresponsible or accountable for equal to \nthe withdrawn amount. \n \n4/ Notwithstanding the provisions of Sub-\nArticles (1) to (3) of this Article, if The \nMinistry or respective Regional Health \nBureau verified that the health facility’s \nregular operations will be affected to the \nextent that it cannot render the health \nservice it provides to the society due to \nthe deduction of its operational budget \ndirectly from its bank account or the \nmedicines it purchases on credit basis \nwill be used for emergency responses \nassociated with man-made or natural \ndisasters, the debt of the health facility \nshould be covered by the Ministry, \nMinistry of Finance or Regional finance \nbureaus  as appropriate. \n \n \n24. Obligations of Health Facilities and the \nService Regarding Pharmaceutical Supply \n1/   Public health facilities shall place orders \nonly to the Service for the supply of \nessential pharmaceuticals; the Service \nshall, in case of failure to supply the \npharmaceuticals, advice the institutions \nof the best alternatives thereof.  \n \n \n780y21\n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17904 \n \n6/ \u0001*?\u0015@Aa 9:;<\u0003E MdC \u001dF'\u0003 \n\u0001'=P\u0013 ;\u000b\u0016\u0003C @N qdC \u001dF'\u0003 \n\u0017\" \u001aG?%( (\u0015 9QP\u0003 \u0001*=\"Z\u0003 \n[\"\\\u0003 \u0001G\u001eWE \u0010^El \u001c\"\u001c\" *DÓÈ \n\u001a99\u0011\u0006 Y\u001eWC\u0015 \n    \n    \n    \nx{\nx{\nx{\nx{. \n. . \n. \u00019ª\u0017?\u0011\u0006\n\u00019ª\u0017?\u0011\u0006\n\u00019ª\u0017?\u0011\u0006\n\u00019ª\u0017?\u0011\u0006 :E\u0017Ï \n:E\u0017Ï \n:E\u0017Ï \n:E\u0017Ï  \n \n\u001a*+, -.\" {231//0y2°y 9WP\u0003 \u001a[\n \n\u000bY \u0006 99\u0011\u0006  \u0001fE *+, :E\u0017Ï  \nBX\u001f\u0015\u001dVP_ :PX BC \u001af *+, 9WP\u0003 \n\u001aG\u001e® \tE\u0013C 99\u0011\u0006  BXqG\u001dU :PX \n\u001dDÅG\u0016NO( Yj.\u000b\u0015 \n \nx£\nx£\nx£\nx£. \n. . \n. 9\u0013\u0003C\n9\u0013\u0003C\n9\u0013\u0003C\n9\u0013\u0003C @NE\n@NE\n@NE\n@NE XM'X\u001d\u000bMh\nXM'X\u001d\u000bMh\nXM'X\u001d\u000bMh\nXM'X\u001d\u000bMh \n \n\u001a*+,    -.\"     /062Ö1/6074        9QP\u0003     \n\u0001\u001dFF9(     “\u0001\u0002\u0003\u0004\u0005\u0006     9:;<\u0003     *=\n> \n*?\u0015@A\u0003”  \n \n9\u0013\u0003C @N \u001af *+, \nM\u001dFF9( “*?\u0015@A\u0003” \u001d\u000b\u0015×\u0015 \n \n    \nx8\nx8\nx8\nx8. \n. . \n. \u0001\u001dk­C\n\u0001\u001dk­C\n\u0001\u001dk­C\n\u0001\u001dk­C \u001dDÅG\n\u001dDÅG\n\u001dDÅG\n\u001dDÅG \u0001'Y^_\n\u0001'Y^_\n\u0001'Y^_\n\u0001'Y^_ \u001b \n\u001b \n\u001b \n\u001b  \n \n// \n\u0001\b\t\n\u0015 \n9E@X\u0003 \n*XDÅG \n*\u001f\u000b\u0003E \nX\u0015\u0019EC \u001d@%\" M9\u001eWE \u0001\u001e\u0019( *+, \n-.\" /062Ö1/6074 *Ej¯ Öy \u000bY XM \n\u0001\u0002\u0003\u0004\u0005\u0006 9:;<\u0003 *=\n> *?\u0015@A\u0003 \n\u0001\u001d\t\u0016??( \u001af *+, \u001d\u0015 \n \n \n6/ YfE *+, \u0001GVPE 'Eu(! \u001b@ \u001eY! \n\u0001*W\n\" \u0015!: \u001af *+, \u001a\u001dªD_ rm\u0004  \n\u000bY \u001dDÅG\u0016\u0003 *YeP(! \n \n \nxK\nxK\nxK\nxK. \n. . \n. \tE\u0013C\n\tE\u0013C\n\tE\u0013C\n\tE\u0013C 99\u0011\u0006\n99\u0011\u0006\n99\u0011\u0006\n99\u0011\u0006 \u0001'(\u0019\u0003\n\u0001'(\u0019\u0003\n\u0001'(\u0019\u0003\n\u0001'(\u0019\u0003 [\u0015\u0019E\n[\u0015\u0019E\n[\u0015\u0019E\n[\u0015\u0019E \n \n//     \u0001G<X\u0003p     !\u000f\"      #\u0003 YfEE     *+,   \n M'XDÈ!  \u0001G\u0006XD\u0015@    \tE\u0013     \u0014\u0006\u001e\u0019 \nY \u000b\u0015 \n \n6/  *?\u0015@Aa  \u0001fE  *+,  \\\u000b'   q@\u0013  \nM':PX  BC  \u001af  *EjJ  E¿X-\n*EjJ  (/) \n9QP\u0003 \n\u0001G\u001e\u0019 \n\tE\u0013E \nM'XD¤! \u0001GP¡ 99\u0011\u0006 E \u0014\u0006\u001e\u0019 \nY \u000b\u0015 \n \n \n \n2/ The Service's responsibility to supply \npharmaceuticals to health facilities is \ndetermined by the committed demand \nsystem agreed upon by the two parties in \nthe \ncontract; \nthe \ndetails \nshall \nbe \ndetermined by the Directive. \n \n25.  Transitional Provisions \n \nDirectives issued based on 553/2007 shall \ncontinue to be applied until they are not \ncontravene to provisions of this Proclamation \nand replaced by Directives issued for the \nexecution of this Proclamation. \n \n26.  Transfer of Rights and Obligations \n \nThe \nrights \nand \nobligations \nof \nthe \n\"Pharmaceutical Supply Agency\" established \nby Proclamation No. 1263/2021 shall be \ntransferred to the \"Service\" established by \nthis Proclamation. \n \n27.  Repealed and Inapplicable Laws \n \n1/ The provision of Article 69 of the \nProclamation No. 1263/2021 issued to \ndetermine the powers and functions of \nthe executive bodies of the Federal \nGovernment \nregarding \nEthiopian \nPhamaceutical \nSupply \nService \nis \nrepealed by this Proclamation. \n \n2/ Any law or practice contrary to this \nProclamation shall not apply with respect \nto matters covered by this Proclamation. \n \n28.  Power to Issue Regulation and Directive \n \n1/ The Council of Ministers may issue \nRegulation necessary to implement this \nProclamation. \n \n2/ The Service may issue Directives for \ncarrying out the objectives of this \nProclamation and for the enforcement of \nthe Regulation issued pursuant to Sub-\nArticle (1) of this Article; \n \n \n \n780y24 \n\n       gA                   Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M   Federal   Negarit  Gazette No. 29, 13th  March,  2025 ….page                          \n \n \n \n17905 \n \nxy\nxy\nxy\nxy. \n. . \n. *+¬\n*+¬\n*+¬\n*+¬ \u0001G¤C\u001a\u0003\n\u0001G¤C\u001a\u0003\n\u0001G¤C\u001a\u0003\n\u0001G¤C\u001a\u0003 ]\u0018\n]\u0018\n]\u0018\n]\u0018 \n \nYf *+, \u001a\b\n\u0015 \u0016\u0017\u0011\u0003 \u0017\u0018\u0019 N\u0003\u000e \nq\u001e\u0019\u001a\u0003 jE !p \u0001¤C Y^C\u0015  \n \n*\rX\n*\rX\n*\rX\n*\rX *\u001a%\n*\u001a%\n*\u001a%\n*\u001a% 9\u0017>\u0003 4 \n9\u0017>\u0003 4 \n9\u0017>\u0003 4 \n9\u0017>\u0003 4 jE\njE\njE\njE 6078\n6078\n6078\n6078 \\.! \n \n \nNØ\nNØ\nNØ\nNØ *Jj[\u000b½\n*Jj[\u000b½\n*Jj[\u000b½\n*Jj[\u000b½ \n \n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006\n\u0001\u0002\u0003\u0004\u0005\u0006 \b\n\u000b\f\n\b\n\u000b\f\n\b\n\u000b\f\n\b\n\u000b\f \r\u000e\u000f\n\u0010\u0006\f\n\r\u000e\u000f\n\u0010\u0006\f\n\r\u000e\u000f\n\u0010\u0006\f\n\r\u000e\u000f\n\u0010\u0006\f \n \n\u0011\u0012\u0013\u0014\u000f\n\u0011\u0012\u0013\u0014\u000f\n\u0011\u0012\u0013\u0014\u000f\n\u0011\u0012\u0013\u0014\u000f »mE\u0003\n»mE\u0003\n»mE\u0003\n»mE\u0003 \n \n \n \n \n \n \n \n28.  Effective Date \n \nThis Proclamation shall come into force up \non Publication in the Federal Negarit \nGazettee. \n \nDone at Addis Ababa, on this 13th day of \nMarch, 2025 \n \nTAYE ATSKE SELASSIE \n \n \nPRESIDENT OF THE FEDERAL \n \nDEMOCRATIC REPUBLIC OF ETHIOPIA \n \n \n \n \n \n \n \n \n \n \n \n780y2{ \n",
  "cleaned_text": "gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page",
  "normalized_text": "gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page gA Ød‰L ነU¶T Uz¤È qÜ_R xy 9\u0017>\u0003 4 jE 6078 ›.M Federal Negarit Gazette No. 29, 13th March, 2025 ….page",
  "file_hash": "0db06bae0916661b503ca28095adfe1d"
}